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Chapter 1. Introduction 
1.1. Introduction 
Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels in 
the post-synaptic plasma membrane that receive chemical signals released from 
presynaptic neurons. The opening of nAChRs is triggered by the neurotransmitter 
acetylcholine. nAChRs are broadly present in many tissues including nervous 
systems and muscle systems. In nematodes, nAChRs are targets of nicotinic anti-
parasitic drugs, such as levamisole. Like acetylcholine, levamisole is a nAChR 
agonist. Two molecules of levamisole bind with the receptor to open the 
transmembrane tunnel, which is formed by five subunits. This drug is effective to 
treat parasitic nematode infections in humans and domestic animals. However, drug 
resistance emerges and spreads after long-term repeated use of levamisole. Drug 
resistance can occur naturally. The phenomenon of drug resistance may be due to 
many mechanisms linked to the ACh-signaling cascade (Jones and Sattelle, 2004). 
My studies focused on levamisole action and diversity of nAChRs. It was known that 
multiple nAChR subtypes are present on somatic muscle cells in nematodes and the 
levamisole sensitivities of the subtypes are different. We used the patch-clamp 
technique to record ion channel signals of individual receptors and analyzed the 
single-channel properties. First we tested nAChR subtypes in the parasitic nematode 
Ascaris suum. Then we realized that genetically manipulated C. elegans could 
provide a good model for levamisole resistance. Therefore we developed single-
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channel recording in C. elegans to investigate the levamisole sensitive receptor 
properties and receptor modulation. We believe that our results will help estimate 
how good C. elegans is as a model for studies of parasitic nematodes. 
1.2. Thesis Organization 
In chapter 2, the background information on the parasitic nematodes Ascaris 
spp. and the free-living nematode C. elegans is reviewed, as well as the molecular 
and genetic information on nematode nAChRs. My PhD study included three 
projects and each project was reported here as individual chapter (Chapter 3, 4 and 
5). In chapter 3, I described the three nAChR subtypes observed in Ascaris. This 
study has been published (Qian et al., 2006). I conducted all of the studies reported 
in this chapter, with the exception of Figure 3.6, which was made by Alan Robertson.  
In chapter 4, I described the levamisole sensitive nAChR observed in C. elegans. In 
chapter 5, I described the single-channel study of two nAChR subunits, LEV-1 and 
LEV-8. The studies described in these two chapters will be submitted for publication. 
Alan Robertson and Richard Martin will be co-authors for both of the studies.   In 
chapter 6, the general discussion, I summarize the observations of my PhD studies 
and discuss the significance of the observations. 
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Chapter 2. Literature review 
2.1. Nematode parasites and the model nematode 
Parasites spend part of their life cycle in or on another living organism, such 
as humans. During the relationship, the host provides food for growth and survival of 
the parasite. The parasite induces parasitic disease in the host and can cause poor 
growth or even death. In a WHO report (WHO, 2000), it was observed that globally 
17.3 million deaths of humans were due to infectious and parasitic diseases annually. 
Common parasitic nematoda include: round worms (Ascaris lumbricoides, 
Strongyloides stercoralis), hook worms (Ancylostoma duodenale, Necator 
americanus), pinworm (Enterobius vermicularis), filaria (Dirofilaria immitis, 
Wuchereria bancrofti, Brugia malayi and whipworm (Trichuris trichiura). In my 
studies, the parasitic nematode Ascaris suum and the free-living nematode C. 
elegans currently are used as animal models. In this chapter, the life cycle and 
similarity of these two nematodes are discussed. 
2.1.1. Ascaris and ascariasis 
Nematode parasitic diseases commonly occur in human and domestic 
animals. One of the nematode parasitic diseases in man is ascariasis induced by 
Ascaris lumbricoides. Ascaris are large nematodes: adult females are 20-40 cm in 
length and 0.3-0.6 cm in diameter; adult males are 15-30 cm in length and 0.2-0.4 
cm in diameter. Adult females are easily recognized by their large ovaries which 
occupy the posterior ~60% of the worm. There are two Ascaris species: Ascaris 
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lumbricoides (A. lumbricoides) in humans and Ascaris suum (A. suum) in pigs. The 
only anatomical difference between these two species is that A. suum has a row of 
small teeth on the lips (Sen et al., 1963). Although they are very similar, infection of 
man with A. suum or pigs with A. lumbricoides is rare (Urquhart et al., 1987). Both 
Ascaris species are distributed worldwide. Figure 2.1 shows the life cycle and 
infection pathway of A. lumbricoides. Adults are normally found in the lumen of the 
small intestine. A female is reported to release about 200,000 eggs per day, which 
are passed with the feces. Infective eggs contaminate food and water. Following 
ingestion of contaminated food or water, larvae hatch in the host intestine. Larvae 
migrate through the intestinal wall and then reach the lungs.  After molting, L4 larvae 
migrate up the trachea and are swallowed.  The L4 larvae then develop into adults in 
the small intestine. When infected by Ascaris, the host feels abdominal pain and 
nausea with disturbed function of the alimentary tract. When larvae arrive in the 
lungs, the host may have some respiratory symptoms. 
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Feces
Fertilized
Unfertilized  
Figure 2.1. (Modified from http://www.thelifetree.com/roundworms.com) The 
life cycle of A. lumbricoides. Adult A. lumbricoides are found in the lumen 
of the small intestine. The eggs produced by females are defecated with 
feces. Infective eggs contaminate food and water. Following ingestion of 
contaminated food or water, larvae hatch in the host intestine. Larvae 
migrate through the intestinal wall, pass through the liver and then reach 
the lungs. After molting, L4 larvae migrate up the trachea and are 
swallowed.  L4 larvae then develop into adults in the small intestine. 
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2.1.2. Caenorhabditis elegans 
Caenorhabditis elegans (C. elegans), a free-living nematode in soil 
environments, has both a hermaphrodite sex and a small male population. Since the 
distinguished studies done by Sydney Brenner in the 1970’s, this nematode is used 
extensively as an experimental model system for genetic and molecular studies. The 
reason for choosing this worm as the animal model is because: 
y The life cycle of C. elegans is very rapid; 
y It is easy to maintain in laboratory; 
y It shows a large variety of behaviors and responses that can be tested; 
y It has the advantage of being a multicellular organism as well as 
simple; 
y The complete cell lineage has been determined; 
y Many aspects of development have been studied; 
y The entire genome has been sequenced; 
y Many open sources are available; 
y Advanced molecular technologies are available in C. elegans. 
 
C. elegans has four larval stages (Figure 2.2), L1, L2, L3 an L4. Each stage 
lasts 10 - 14 hours at 20 oC. The complete life cycle is ~3.5 days at 20oC. Under 
certain environmental conditions the worm goes through a dauer larval stage and 
can survive for months. A single hermaphrodite can produce 300-350 progeny and a 
mated hermaphrodite can produce over 1000 progeny. 
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Figure 2.2. The life cycle of C. elegans. After hatching, the worm has 4 
larvae stages and 1 adult stage. At 20oC the life time of the worm is 3 – 4 
days. In certain environments, the worm may go through a dauer stage 
to survive for a long period. 
 
C. elegans can easily be maintained on bacterial-seeded agar plates. The 
bacteria Escherichia coli (E. coli) are the food for the worm. The worm is transferred 
from one plate to another and grows to a large population in a few days. When large 
scale worm preparation is needed, liquid culture is an alternative. C. elegans also 
can be frozen and stored at -70 oC. 
The animal is transparent and its development can be traced. The 
developmental fates of the somatic cells (959 in adult hermaphrodites; 1031 in the 
adult male) have been mapped (Sulston and Horvitz, 1977; Sulston et al., 1983). 
The development pattern of the simple nervous system (302 neurons in 
hermaphrodites) also has been reconstructed (White et al., 1983). 
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C. elegans shows many behaviors and responses, i.e. locomotion, 
pharyngeal pumping, defecation, touch response, chemosensation and 
thermosensation. Individual neurons associated with these behaviors have been 
studied in some detail (Riddle, 2001). 
The C. elegans Sequencing Project was a collaboration between the Sanger 
Center in Cambridge, UK and the Genome Sequencing Center at the University of 
Washington, St. Louis, USA. The sequencing of the complete genome in 1998 
makes C. elegans quite convenient for genetic analysis. As of March 2007 there 
were 24,019 genes in C. elegans released by WormBase W173. These genes 
distribute on 5 autosomes and 1 sex chromosome. The gene structure and 
sequence are available from WormBase (http://www.wormbase.org/) and nucleotide 
& protein databases (GenBank/EMBL/DDBJ/UniProt). The Caenorhabditis Genetics 
Center at the University of Minnesota (http://www.cbs.umn.edu/CGC/) maintains a 
huge database of C. elegans strains. As an addition to the genomic sequencing, the 
C. elegans EST Project helps to confirm the open reading frames. By the help of this 
project, the molecular information of more than 90% of the genes is available. 
Since sequencing of the C. elegans genome was completed, many genetic 
and molecular methods have been found to reliably work in this animal. Forward 
genetics and genetic mapping help scientists to generate mutations to analyze gene 
function and phenotypes.   As an important complement to forward genetics, reverse 
genetic methods allow us to knockout almost any gene in the genome. Among those 
techniques, RNA interference (RNAi) is one of the most successful. Up to March 
2007, RNAi clones of 19,856 worm genes, which cover more than 80% of the 
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genome, are available. It is not clear that they all work. Some genes are not 
susceptible to RNAi, especially in neurons. DNA microarray is another advanced 
technique, which allows scientists to assess the expression level of every gene in C. 
elegans in a rapid and economical way. 
2.1.3. C. elegans as a model for parasitic nematodes 
C. elegans is commonly used as model for parasitic nematodes. However, C. 
elegans is a free-living animal not a parasite. This gives rise to the question whether 
C. elegans is a good model for parasite studies. 
First we need to know how C. elegans is evolutionally similar to parasitic 
nematodes. To date the evolution positions of C. elegans and parasitic nematodes 
were not defined clearly. Usually parasites are classified as separate groups from 
free-living nematodes and evidences of morphological studies assumed that 
parasites developed from free-living species (Anderson, 1992). By comparing the 
similarity of homologous proteins from different nematode species, the relationships 
of C. elegans and the parasite groups are reconstructed. Molecular studies 
proposed other new schemes of nematode systematics (Lorenzen, 1994; Malakhov 
and Hope, 1994). For example, the molecular phylogenetic analysis of small subunit 
(18s) rRNA genes indicate that C. elegans belongs to the Rhabditida order (Figure 
2.3), which is most closely related to parasitic Strongylida (Zarlenga et al., 1994; 
Zarlenga et al., 1994; Fitch et al., 1995; Baldwin et al., 1997; Blaxter et al., 1998; 
Burglin et al., 1998).  
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Triplonchida
Enoplida
Chromadorida
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Figure 2.3. (Duplicated from Burglin et al.,1998) The molecular phylogenetic 
tree of nematodes. The model nematode C. elegans belongs to the 
Rhabditida and the parasitic nematode Ascaris belongs to the Ascaridida 
order. 
 
Another way to evaluate how good C. elegans is a model for parasites is the 
comparison of genomes between C. elegans and parasites. Inspired by the C. 
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elegans Genome Project, the World Health Organization sponsored the Filarial 
Genome Project since 1995. Initial focus was to generate the EST database of the 
human filarial parasite Brugia malayi. B. malayi shared the same ancestor with C. 
elegans 300-500 million years ago (Vanfleteren et al., 1994). It was predicted that B. 
malayi has at least 18,500 genes (Whitton et al., 2004). This number is close to that 
of C. elegans. More than 25,000 ESTs have been generated and grouped into 8348 
clusters. About 40% of them show homologs in C. elegans (Geary and Thompson, 
2001). 
Furthermore, neurobiological aspects between C. elegans and parasites, 
such as neuropeptides, have also been studied. Neuropeptides act as signal 
transmitters in nematode nervous systems to modulate animal behaviors. More than 
100 genes encoding over 250 neuropeptides have been discovered in C. elegans. 
The neuropeptides are conserved in nematode systems. Many of them are identical 
or highly similar between C. elegans and parasitic nematodes, such as Ascaris, 
Haemonchus (Geary et al., 1999; Li, 2005). 
Overall, many evidences support that C. elegans is likely to be a good model 
for parasitic nematodes. This organism is commonly used in studies of 
pharmacology and development of antiparasitic drugs (Geary and Thompson, 2003; 
Brown et al., 2006). It is reasonable and necessary to consider this animal as the 
model for drug resistance studies. However, there are some limitations to using C. 
elegans as a model for studying of parasitic nematodes. Such as, although the 
peptides are similar in C. elegans and parasites, their expression and functions may 
vary between species (Maule et al., 2002). Another significant difference between C. 
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elegans and parasites is the diversity of nicotinic receptors. Unpublished data 
indicate that C. elegans is not sensitive to the nematode nAChR antagonist 
paraherquamide, which potently inhibits the nicotinic receptors in Ascaris (Geary, 
pers. comm.). 
2.2. Nervous system in nematodes 
There are several ways to define the neuron class in nematodes. According 
to their physiological functions neurons are classified as sensory, interneurons or 
motorneurons. Based on the type of neurotransmitter produced by the neuron, 
neurons are classified as cholinergic, GABAergic, etc. A more refined method used 
to classify nematode neurons is based on their anatomical features. With this 
classification, neurons in C. elegans are defined into 118 classes and individual 
neurons are distinguished by their relative position to the anterior/posterior or 
left/right axis (White et al., 1986). Here, I briefly introduce the anatomical structure of 
nematodes using A. suum as example. Then the structure of commissures is 
explained using C. elegans as example. 
2.2.1. Anatomical structure of nervous system in nematodes 
The central nervous system of Ascaris is near the head and consists of a set 
of ganglia associated with a nerve ring (Figure 2.4). This ring receives the primary 
sensory input and gives rise to the cephalic muscle motor output. Two major nerve 
cords, dorsal and ventral, originate from the nerve ring (Figure 2.4 and Figure 2.5). 
There is also one small lateral nerve cord on each side, named the dorsal lateral and 
ventral lateral nerve cords (Del Castillo et al., 1989). 
 
 13
 
Mouth and lips
Nerve ring
Dorsal nerve
Dorsal lateral nerve
2 mm
Ventral nerve
 
Figure 2.4. (Crompton and Joyner, 1979) The anterior part of the nervous 
system in Ascaris. The nerve ring receives the primary sensory input and 
gives rise to the cephalic muscle motor output. The two major nerve 
cords, dorsal and ventral, originate from the nerve ring  
 
The anatomical studies show that the cell bodies of motorneurons are located 
in the ventral nerve cord and connect with the dorsal nerve cord through one left-
hand and three right-hand commissures (Figure 2.6). According to their anatomical 
features, there are seven classes of motorneuron: dorsal excitatory DE1, DE2 and 
DE3; ventral excitatory VE1 and VE2; dorsal inhibitory DI and ventral inhibitory VI. 
The connection commissures are arranged in a pattern along the nematode body 
forming five segments and each segment contains eleven motorneurons: one of DI, 
DE2 and DE3, two of DE1, VI, V1 and V2 (Stretton et al., 1978). 
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Dorsal nerve cord
Syncytium
Muscle bag
Lateral canal
Lateral line
Perienteric fluid
Hypodermis
Cuticle
Ventral nerve cord1 mm  
Figure 2.5. (Thorn and Martin, 1987) Transverse section of Ascaris. The 
dorsal and ventral nerve cords are indicated as well as the two small 
lateral nerve cords. The two lateral lines separate somatic muscles into 
ventral and dorsal layers. 
 
 
Figure 2.6. (Martin et al., 1996) Diagram of the dorsal and ventral nerve cord 
in one segment of Ascaris. Seven anatomical types of motorneurons are 
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present: dorsal excitatory (DE1, DE2 and DE3), dorsal inhibitory (DI), 
ventral inhibitory (VI), ventral excitatory (V1 and V2). 
{ Inhibitory motorneuron 
z Excitatory motorneuron 
U Inhibitory output 
S Excitatory output 
 
2.2.2. Nervous commissures in nematodes 
In the nervous system of nematodes, most neuron processes form ventral 
and dorsal nerve cords along the body axis. However, some processes make dorso-
ventral transitions between the long nerve cords. These transitions are called 
commissures. In the head, there are two pairs of commissures, right & left amphid 
commissures and right & left deirid commissures. In the tail, there are three pairs of 
commissures, right & left lumbar, right & left dorsorectal commissures, and right & 
left dorsolateral commissures. An enlarged commissural region comprised with ~200 
processes encircles the pharyngeal bulb and forms the nerve ring. In the pharynx, 
there are two commissures, pharyngeal nerve ring & terminal bulb commissures. 
Along the body, more than 40 commissures grow out from the ventral nerve cord to 
connect the dorsal nerve cord (White et al., 1986; Hedgecock et al., 1987). 
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2.3. Body wall muscle cell and neuromuscular junction in 
nematodes 
Body wall muscle cells in nematodes are separated into ventral and dorsal 
layers (Stretton, 1976; Del Castillo et al., 1989). Each somatic muscle cell has three 
parts (Figure 2.7): a spindle region which is anchored to the hypodermis, a balloon-
like bag which contains the nucleus, and arms which arise at the base of the bag 
region and extend to the nerve cord. The structure of the somatic muscle cell and 
neuromuscular junction in Ascaris is introduced here as an example. 
2.3.1. Belly 
The belly or bag region of the Ascaris muscle cell is in the pseudocoelomic 
space. The cortical region of the belly contains fibrillar bundles of cytoskeleton and a 
row of small mitochondria. The belly serves as an endoskeleton. The cytoplasm 
contains the nucleus and is filled with glycogen particles. These glycogen particles 
are depleted during starvation or exercise (Rosenbluth, 1965). 
2.3.2. Arm 
The arm is a thin process rising from the muscle belly. One muscle cell may 
have more than one and up to five arms (Rosenbluth, 1965). When the arms arrive 
at the nerve cord, they separate into several processes in bundles with gaps of 400-
500 nm. The arms come together to form a structure called “syncytium” (Del Castillo 
et al., 1989). Synapses are formed between the syncytium and the nerve cord. 
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Figure 2.7. (Rosenbluth, 1965) Schematic diagram of the muscle cell and 
the neuromuscular junction. The muscle cell includes a spindle, a belly 
(or bag) and arms. The neuromuscular junction is formed between the 
end of the arms (which forms a syncytium) and the nerve cord. n: nerve 
cord; h: hypodermis; c: cuticle. 
 
2.3.3. Spindle 
The spindle region contains the contractile apparatus of the muscle cell 
forming a long tube lying against the hypodermis. It was suggested that the Ascaris 
 
 18
muscle cell is obliquely striated and has properties between smooth and striated 
muscle (Rosenbluth, 1965). 
2.4. Physiology of the body-wall muscle cell in nematodes 
2.4.1. Membrane potential of the muscle cell 
The electrical activity of the somatic cells of Ascaris has been studied. The 
average resting membrane potential of the belly region is about -30 mV (Debell et al., 
1963). The membrane potential varies with different bathing solutions. For example, 
the average value was -29.8 mV in diluted (30%) sea water and -34.5 mV in the 
perienteric fluid (Del castillo et al., 1964). One of the features of the resting 
membrane potential of Ascaris muscle cells is the relative insensitivity to change in 
the composition of extracellular concentrations of Na+ and K+ (Brading and Caldwell, 
1971). However, changes of external Cl- concentration affects the membrane 
potential (Del Castillo et al., 1964). It was proposed that there is a Cl- battery in the 
membrane to maintain the potential. This hypothesis was doubted by Brading and 
Caldwell. A modified Goldman-Hodgkin-Katz equation 
yClPNaPKP
xClPNaPKP
F
RTE
oCliNaiK
iCloNaoK
+++
+++=
][][][
][][][
ln  
was proposed to explain the insensitivity of membrane potential to K+ and Na+ 
(Brading and Caldwell, 1971). Two large addition components represented by x and 
y suggests the existence of an electrogenic ion transport system, which may be a 
Na+ transporter. 
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2.4.2. Spontaneous electrical activity of the muscle cell 
The steady membrane potential is rhythmically interrupted by spontaneous 
depolarizations with a frequency of 1.5-7 per second (Debell et al., 1963). The 
spontaneous activity (Figure 2.8) has three phases: slow waves lasting up to 0.2 sec, 
spikes of ~22 ms duration and transient post-spike hyperpolarization (Del Castillo et 
al., 1989). It was observed that stimuli at the belly region of the muscle cell with 
external electrodes failed to induce propagated electrical activities, while electrical 
stimulation to the nerve cord gave rise to potential activities similar to the 
spontaneous activities. These observations suggest that the spontaneous 
postsynaptic activity is due to the release of neurotransmitters from the presynaptic 
nerve cord. These “pacemaker” potentials passively propagate from the arm regions 
of the muscle cells to the bag regions. Del Castillo concluded that the amplitude of 
the slow waves and the frequency of the spikes were modulated by the interplay of 
neurotransmitters ACh (excitatory) and GABA (inhibitory). 
2.4.3. Patch-clamp technique in nematodes 
The patch-clamp technique is a refinement of the voltage clamp technique. 
This technique was developed by Erwin Neher and Bert Sakmann in the late 1970s 
and early 1980s. They received the Nobel Prize in 1991 for this work. The 
development of a high resistance contact (up to 10 giga ohm) between a glass 
electrode pipette and cell membrane dramatically reduces the background noise and 
gives the possibility to study individual ion channels. Back in the 1980s, the patch-
clamp technique was described to record the single-channel current of acetylcholine 
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receptors (Hamill et al., 1981). Since 1985, this technique was used in nematodes to 
study the ion channel located on the body wall muscle (Martin, 1985). Later, it was 
found that single-channel recording is a very powerful technique to investigate the 
subtypes of ion channels and the channel properties of different subtypes were 
distinguishable (Pennington and Martin, 1990; Martin et al., 1991). Because of the 
small size, C. elegans was difficult to be dissected for electrophysiological 
investigations. Until 1999, Janet Richmond developed a C. elegans preparation to 
record the whole-cell current from the body wall muscle cell (Richmond and 
Jorgensen, 1999). 
 
0 mV
 
Figure 2.8. (Debell et al., 1963) An example of spontaneous electrical 
activities recorded from the bag region of Ascaris muscle cells. Each 
spontaneous activity has three phases: a slow wave, a spike and a 
transient post-spike hyperpolarization. 
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2.5. Neurotransmitters and their receptors in nematodes 
In C. elegans, acetylcholine, glutamate, GABA, dopamine and serotonin have 
been found to exist as neurotransmitters. Other amine transmitters of vertebrates 
such as histamine, epinephrine and norepinephrine are not detected. In this chapter, 
the distribution and function of the neurotransmitters as well as their receptors are 
introduced. 
2.5.1. Acetylcholine 
Acetylcholine (Figure 2.9) is one major neurotransmitter in nematodes. More 
than a third of the neurons in C. elegans release acetylcholine 
(http://www.wormbook.org). Cholinergic transmission occurs both between neurons 
and at the neuromuscular junction. Acetylcholine is an excitatory transmitter. 
However, acetylcholine-gated chloride channels also were found. That suggests that 
acetylcholine could be an inhibitory transmitter in some C. elegans cells. Cholinergic 
transmission is involved in many nematode behaviors, including locomotion, egg 
laying, pharyngeal pumping, defecation cycling, and male mating 
(http://www.wormbook.org). 
As in vertebrates, acetylcholine targets ionotropic ACh receptors and G-
protein coupled ACh receptors in nematodes. The ionotropic nicotinic ACh receptors 
will be introduced in detail later. G-protein coupled ACh receptors are similar to 
vertebrate muscarinic receptors. This muscarinic AChR (mAChR) was found in 1983 
(Culotti and Klein, 1983). Three genes, gar-1, gar-2 and gar-3, encode mAChRs. 
The primary transcriptions from the genes are alternatively spliced and give different 
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receptor isoforms (Park et al., 2000; Suh et al., 2001; Park et al., 2003). The GAR-3 
isoforms are the most similiar to vertebrate muscarinic AChRs. It was found that gar-
1 and gar-2 are expressed in sensory and motor neurons (Lee et al., 2000), and gar-
3 is expressed in pharyngeal muscle (Steger and Avery, 2004). 
 
 
Figure 2.9. The chemical structure of acetylcholine. Acetylcholine is 
synthesized from choline and acetyl-CoA by choline acetyltransferase 
(ChAT), and degraded by acetylcholinesterases (AChE). 
 
In addition to excitatory ionotropic AChRs, four subunits (ACC-1, ACC-2, 
ACC-3 and ACC-4) were found to form ACh-gated chloride channels in C. elegans. 
No orthologs were found in vertebrate or Drosophila genomes (Putrenko et al., 
2005). The expression patterns and functions of these ion channels remain to be 
studied. 
2.5.2. Glutamate 
Glutamate (Figure 2.10) exists in C. elegans as an excitatory and an inhibitory 
neurotransmitter. Glutamatergic neurotransmission mediates rapid excitatory 
synaptic signaling. At least 10 excitatory glutamate receptor subunits exist in C. 
elegans. GLR-1 – GLR8 are similar to non-NMDA receptors in vertebrates. NMR-1 
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and NMR-2 are similar to NMDA receptors (Brockie et al., 2001; Brockie and Maricq, 
2003). There is also a family of glutamate-gated chloride channels (GluCl) in 
nematodes. Six genes encode multiple subunits of the GluCl receptors in C. elegans. 
GluCl receptors have been found in other nematodes such as Ascaris and 
Haemonchus (Cully et al., 1996; Forrester et al., 1999; Jagannathan et al., 1999), 
and are the target of the anti-parasitic drug avermectin (Cully et al., 1994). 
 
COOH
H2N C H
CH2
CH2
COOH  
Figure 2.10. The chemical structure of glutamate. Glutamate is also referred 
to as glutamic acid. 
 
The distribution of GluR subunits has been studied with the help of GFP-tag 
expression. NMDA-like subunits are expressed in command interneurons, while non-
NMDA-like subunits are expressed in both interneurons and the pharyngeal nervous 
system (Hart et al., 1995; Maricq et al., 1995; Brockie et al., 2001). Based on the 
receptor distribution it has been suggested that GluRs are involved in the avoidance 
of noxious stimuli and the control of pharyngeal pumping. GluCl receptors are found 
to be expressed in pharyngeal muscle and neurons and involved in pharyngeal 
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pumping, sensory perception and locomotion (Dent et al., 1997; Laughton et al., 
1997; Vassilatis et al., 1997; Dent et al., 2000). 
2.5.3. GABA 
GABA (γ-aminobutyric acid) is an amino acid neurotransmitter (Florey and 
McLennan, 1955; Bazemore et al., 1956). In C. elegans, GABA exists as a 
neurotransmitter in 26 of the 302 neurons. GABA neurons are conserved in 
nematodes (Johnson and Stretton, 1987; Guastella et al., 1991). GABA inhibits  
muscle contraction and foraging movements, but stimulates the enteric muscle 
during defecation (McIntire et al., 1993).  
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Figure 2.11. The chemical structure of GABA. GABA is decarboxylated from 
glutamate by glutamic acid decarboxylase. 
 
Two types of GABA receptors exist in nematodes, GABAA and GABAB. 
GABAA receptors are associated with Cl- channels (Delcastillo et al., 1963). The 
activation of GABAA receptors inhibits cell activity. GABAB is a Gi/o-coupled receptor 
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(Campbell et al., 1993). The activation of GABAB inhibits voltage-gated Ca2+ 
channels or activates K+ channels. 
2.5.4. Dopamine 
In hermaphrodites, eight neurons make dopamine (Figure 2.12) as a 
neurotransmitter. In males, six additional neurons in the tail make dopamine. 
Dopamine signaling is critical for learning and modulates locomotion behavior based 
upon the environment (Sawin et al., 2000). Dopamine signaling allows worms to 
search for food and alter their behavior by previous experience (Rose and Rankin, 
2001). The dopaminergic system also contributes to another form of learning, 
odorant adaptation (Colbert and Bargmann, 1995; Bettinger and McIntire, 2004). 
 
CH2 CH2 NH3+
HO
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Figure 2.12. The chemical structure of dopamine. Tyrosine is taken up into 
dopminergic neurons by amino acid transporters, then hydroxylated into 
L-DOPA by tyrosine hyroxylase. Subsequently, L-DOPA becomes 
decarboxylased to dopamine by dopa-carboxylase. 
 
Four dopamine receptors (DOP-1 – DOP-4) have been found in C. elegans. 
DOP-1 is similar to D1-like dopamine receptors in mammals (Suo et al., 2002). 
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DOP-4 also is highly homologous to D1-like receptors (Sugiura et al., 2005). DOP-2 
and DOP-3 are D2-like receptors (Suo et al., 2003; Chase et al., 2004). 
2.5.5. Serotonin 
Serotonin (Figure 2.13) is synthesized in eight types of neurons in C. elegans. 
Treatment with exogenous serotonin (Horvitz et al., 1982; Weinshenker et al., 1995; 
Waggoner et al., 1998) or genetic knockout of serotonin synthetic enzymes (Loer 
and Kenyon, 1993; Waggoner et al., 1998) will cause defects of locomotion but 
stimulate egg laying. Serotoninergic motor neurons in the pharynx might release 
serotonin to communicate with other parts of the body. This signaling allows worms 
to remain in the area of food. Serotonin is also made in VC4/5 and HSN neurons 
that directly innervate the vulval muscle (Desai et al., 1988; Duerr et al., 1999). 
Three G protein coupled serotonin receptors (SER-1, SER-4 and SER-7) and 
one serotonin-gated chloride channel (MOD-1) have been identified in C. elegans 
(Olde and McCombie, 1997; Hamdan et al., 1999; Ranganathan et al., 2000; 
Hobson et al., 2003). SER-1 is expressed on the vulval muscles and pharyngeal 
muscles (Dempsey et al., 2005). SER-4 and SER-7 are expressed in pharyngeal 
neurons and muscles (Hobson et al., 2003; Tsalik et al., 2003). The expression of 
MOD-1 has not been determined. 
 
 
 27
CH2
CH2
NH2
OH
HN
 
Figure 2.13. The chemical structure of serotonin. Serotonin (5-
hydroxytryptamine, or 5-HT) is synthesized from the amino acid 
tryptophan by tryptophan hydroxylase and amino acid decarboxylase. 
 
2.6. Nicotinic acetylcholine receptors 
Nicotinic acetylcholine receptors (nAChRs) are ionotropic receptors activated 
by the neurotransmitter acetylcholine and nicotinic agonists, such as nicotine. 
nAChRs belong to the large superfamily of ligand-gated ion channels (LGIC) that 
includes 5-HT3, GABAA, and glycine receptors (Cockcroft et al., 1990). The 
hierarchy of the ligand-gated ion channel family is shown in Table 2.1. 
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Table 2.1. Ligand-gated ion channels (modified from Le Novère & Changeux, 
1999). 
Superfamily of nicotinicoid receptors 
family of nicotinic receptors 
subfamily of epithelial receptors 
subfamily of neuronal α-bungarotoxin sensitive receptors 
subfamily of muscle receptors 
subfamily of heteromeric neuronal receptors 
subfamily of heteromeric protostomian receptors 
family of serotonin receptors 
family of GABA receptors 
subfamily of GABAA receptors 
subfamily of GABAC receptors 
family of variable agonist receptors 
subfamily of GABA receptors 
subfamily of glutamate receptors 
subfamily of glycine receptors 
Superfamily of excitatory glutamate receptors 
family of excitatory glutamate receptors 
subfamily of NMDA receptor subunits 
subfamily of AMPA receptor subunits 
subfamily of kainate receptor subunits 
subfamily of kainate binding proteins 
subfamily of delta subunits 
Superfamily of ATP receptors 
family of ATP receptors 
  
 
Each receptor is comprised of five subunits. The subunits surround a central 
pore. nAChRs are distributed in the nervous systems and muscle cells. The subunits 
of the receptor fall into two main categories: α and non-α subunits. A vertebrate 
muscle type of nAChRs has two α subunits, one β, one δ, one γ or one ε (Karlin, 
1989). In vertebrate nervous systems, 12 subunits have been identified. Among 
them, α2-α7 and β2 - β4 were found in humans; α8, α9 and α10 were found in chick 
and rat CNS (Graham et al., 2002). In nematodes, nAChR subtypes seem 
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complicated and unclear. To date, in the gene database of the C. elegans Project 27 
genes have been identified to encode nAChR subunits 
(http://www.sanger.ac.uk/Projects/C_elegans/ and http://www.wormbase.com). Here 
we start with the Torpedo nAChR to introduce the ion channel structure. Then we 
focus on the diversity of nAChRs, especially in nematodes. 
2.6.1. The structure of the subunit in Torpedo 
The nAChR located on the electric organ of Torpedo californica was the first 
nAChR purified (Noda et al., 1982; Noda et al., 1983). This muscle type nAChR has 
been well studied from the protein sequences of the subunits to the global structure 
of the receptor. 
The receptor is made up of four subunits α1, β1, γ and δ arranged with a 
2:1:1:1 stoichiometry (Karlin, 1989). Each subunit (Figure 2.14) consists of: (1) a 
large hydrophilic N-terminal domain, (2) four hydrophobic transmembrane domains 
(M1-M4), (3) a small highly variable hydrophilic domain between M3 and M4 and (4) 
a hydrophobic C-terminal domain of approximately 20 amino acids. The large 
hydrophilic N-terminal domain is involved in ligand binding. The M2 transmembrane 
segment folds in an α-helix and contributes to the ion-channel pore (Galzi and 
Changeux, 1995). The nature of the charged amino acids on M2 determines whether 
the channel carries either cations or anions. Experimental evidence indicates a 
common transmembrane topology shared by all subunits (Hucho et al., 1996).  
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Figure 2.14. The secondary structure of the nicotinic acetylcholine receptor 
subunit. Each subunit of the nicotinic acetylcholine receptor consists of a 
large hydrophilic N-terminal domain, four hydrophobic transmembrane 
domains (M1-M4), a small highly variable hydrophilic domain between 
M3 and M4, and a hydrophobic C-terminal domain. 
 
Circular dichroism studies indicate that the N-terminal domain contains an 
abundance of β-strands. The computed structural model suggests that the 
extracellular N-terminal domain of nAChRs consists of a rigid core of β-strands and 
may spontaneously fold to become stabilized into a native-like conformation, which 
reduces the flexibility of the extracellular region (West et al., 1997). The structure of 
this region is changed when ligands, such as acetylcholine, bind with the receptor. 
The change of the N-terminal domain may occur between the subunits but not within 
the interface region. Within the transmembrane domain, electron microscopy reveals 
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that the binding of acetylcholine molecules induce the M2 segments to bend near 
the middle of the membrane and twist around the central axis at the lower part. In 
conclusion, structural changes occur in both the N-terminal and transmembrane 
regions during the allosteric transitions. The global conformational change within the 
transmembrane region is associated with the channel opening (Corringer et al., 
2000). 
2.6.2. The amino acid sequences of nAChR subunits in Torpedo 
The amino acid sequences of this muscle nAChR are the best known. A 
database of the amino acid sequence of LGICs is accessible via the worldwide web 
site: http://www.pasteur.fr/units/neubiomol/LGIC.html. The α subunits contain vicinal 
cysteine residues near position 190 that form part of the acetylcholine binding site 
(Kao and Karlin, 1986). The amino acid sequences of the Torpedo acetylcholine 
receptor subunits are shown in Figure 2.15. 
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Torpedo alpha   MILCSYWHVGLVLLLFSCCGLVLGSEHETRLVANLLEN--YNKVIRPVEHHTHFVDITVGLQLIQ 
Torpedo beta    MENVRRMALGLVVMMALALSGVGASVMEDTLLSVLFET--YNPKVRPAQTVGDKVTVRVGLTLTN 
Torpedo gamma   ------MVLTLLLIICLALEVRS-ENEEGRLIEKLLGD--YDKRIIPAKTLDHIIDVTLKLTLTN 
Torpedo delta   ---MGNIHFVYLLISCLYYSGCSGVNEEERLINDLLIVNKYNKHVRPVKHNNEVVNIALSLTLSN 
 
Torpedo alpha   LISVDEVNQIVETNVRLRQQWIDVRLRWNPADYGGIKKIRLPSDDVWLPDLVLYNNADGDFAIVH 
Torpedo beta    LLILNEKIEEMTTNVFLNLAWTDYRLQWDPAAYEGIKDLRIPSSDVWQPDIVLMNNNDGSFEITL 
Torpedo gamma   LISLNEKEEALTTNVWIEIQWNDYRLSWNTSEYEGIDLVRIPSELLWLPDVVLENNVDGQFEVAY 
Torpedo delta   LISLKETDETLTSNVWMDHAWYDHRLTWNASEYSDISILRLPPELVWIPDIVLQNNNDGQYHVAY 
 
Torpedo alpha   MTKLLLDYTGKIMWTPPAIFKSYCEIIVTHFPFDQQNCTMKLGIWTYDGTKVSISPESDRPDLS- 
Torpedo beta    HVNVLVQHTGAVSWQPSAIYRSSCTIKVMYFPFDWQNCTMVFKSYTYDTSEVTLQHALDAKGER- 
Torpedo gamma   YANVLVYNDGSMYWLPPAIYRSTCPIAVTYFPFDWQNCSLVFRSQTYNAHEVNLQLSAEEGE--- 
Torpedo delta   FCNVLVRPNGYVTWLPPAIFRSSCPINVLYFPFDWQNCSLKFTALNYDANEITMDLMTDTIDGKD 
                                                                     __________M1 
Torpedo alpha   ----TFMES-------GEWVMKDYRGWKHWVYYT TPYLDITYHFIMQRIPLYFVVNVIIPC CCPD
Torpedo beta    -EVKEIVINKDAFTENGQWSIEHKPSRK----NWRSDDPSYEDVTFYLIIQRKPLFYIVYTIIPC 
Torpedo gamma   -AVEWIHIDPEDFTENGEWTIRHRPAKKNYNWQLTKDDTDFQEIIFFLIIQRKPLFYIINIIAPC 
Torpedo delta   YP GEWEI KN IIRRKPLFY ITPC 
                
IEWIIIDPEAFTEN IHKPAK IYPDKFPNGTNYQDVTFYL VINF
_______________      _________M2________               ________M3 
Torpedo alpha   LLFSFLTGLVFYLPTDSG-EKMTLSISVLLSLTVFLLVIVELIPSTSSAVPLIGKYMLFTMIFVI 
Torpedo beta    ILISILAILVFYLPPDAG-EKMSLSISALLAVTVFLLLLADKVPETSLSVPIIIRYLMFIMILVA 
Torpedo gamma   VLISSLVVLVYFLPAQAGGQKCTLSISVLLAQTIFLFLIAQKVPETSLNVPLIGKYLIFVMFVSM 
Torpedo delta   VLISFLASLAF LPAE G-EKMSTAISVLLAQAVFLLLTSQRLPETALAVPLIGKYLMFIMSLVT 
                
Y S
____________       
Torpedo alpha   SSIIITVVVINTHHRSPSTHTMPQWVRKIFIDTIPNVMFFSTMKRASKEKQE------------- 
Torpedo beta    FSVILSVVVLNLHHRSPNTHTMPNWIRQIFIETLPPFLWIQRPVTTPSPDSKPTIISRAND---- 
Torpedo gamma   LIVMNCVIVLNVSLRTPNTHSLSEKIKHLFLGFLPKYLGMQLEPSEETPEKP--QPRRRSS-FGI 
Torpedo delta   GVIVNCGIVLNFHFRTPSTHVLSTRVKQIFLEKLPRILHMSRADESEQPDWQNDLKLRRSSSVGY 
 
Torpedo alpha   -------NK-------IFADDIDISDIS--------GKQVTGEVIFQTPLIKNPDVKSAIEGVKY 
Torpedo beta    -----EYFIRKPAGDFVCPVDNARVAVQ-PERLFSEMKWHLNG--LTQPVTLPQDLKEAVEAIKY 
Torpedo gamma   MIKAEEYILKKPRSELMFEEQKDRHGLKRVNKMTSDIDIGTTVDLYKDLANFAPEIKSCVEACNF 
Torpedo delta   ISKAQEYFNIKSRSELMFEKQSERHGL--VPRVTPRIGFGNNNENIAASDQLHDEIKSGIDSTNY 
                                           __________M4_______ 
Torpedo alpha   IAEHMKSDEESSNAAEEWKYVAMVIDHILLCVFMLICIIGTVSVFAGRLIELSQEG--------- 
Torpedo beta    IAEQLESASEFDDLKKDWQYVAMVADRLFLYVFFVICSIGTFSIFLDASHNVPPDNPFA------ 
Torpedo gamma   IAKSTKEQNDSGSENENWVLIGKVIDKACFWIALLLFSIGTLAIFLTGHFNQVPEFPFPGDPRKY 
Torpedo delta   IVKQIKEKNAYDEEVGNWNLVGQTIDRLSMFIITPVMVLGTIFIFVMGNFNHPPAKPFEGDPFDY 
 
Torpedo alpha   -------- 
Torpedo beta    -------- 
Torpedo gamma   VP------ 
Torpedo delta   SSDHPRCA  
Figure 2.15. The amino acid sequences of Torpedo nAChR subunits. 
Regions of sequence identity between the subunits are indicated by 
black coloring. Regions of sequence high similarity between the subunits 
are indicated by dark coloring. Regions of sequence low similarity 
between the subunits are indicated by light coloring. The vicinal cysteine 
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residues on the α subunit are indicated by red color. The positions of the 
four transmembrane domains (M1 – M4) are indicated. 
 
2.6.3. The pentameric structure of the nAChR in Torpedo 
The Torpedo nAChR is a pentamer. The three dimensional structure 
information of the receptor from electron microscopy at 4.6 Å resolution shows that 
the five transmembrane proteins create a central pore (Figure 2.16) with an inner 
diameter of ~25 Å (Miyazawa et al., 1999). The pore becomes narrower at the 
transmembrane level, which is suggested to correspond to the gate of the channel. 
Two cavities in the α-subunits located 30 Å above the lipid bilayer surface are 
believed to be the ACh binding sites. The cavities connect by tunnels about 10-15 Å 
to the central water-filled vestibule. 
 
αγ
α δ
 
Figure 2.16. Diagram of the nicotinic acetylcholine receptor, depicting the 
ion channel and the ACh binding sites. 
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The crystal structure of an acetylcholine binding protein reveals the ligand-
binding domain of nAChRs (Brejc et al., 2001). The ligand binding site, which is 
located at the subunit interfaces of α and the adjacent non-α subunits, is contributed 
by six loops: three from α subunit and three from the non-α subunits (Corringer et al., 
2000). All amino acid residues in the binding site are conserved between most of the 
nAChRs except two loops. These two loops have low sequence conservations in the 
nAChR family and this change may lead to variations in ligand binding affinity. For 
example, it has been shown that the binding affinities of the α/γ and α/δ are 
pharmacologically different (Sine, 1993; Sine et al., 1995). 
2.7. Nicotinic AChRs in Ascaris suum 
>CAA09602
1 araknyggvs vlyvpyemiw vpdivlynna dsnynit ist katlhysgev tweppaifks
61 mcqidvrwfp fdeqkchlkf gswtysedll vlelldgeph yeletnefge vdnitivddg
121 idlsdyypsv ewdimsrvai r r tknypscc pqsdayidim yylelr rkpl fytvnlvfpc
181 vgisflt i lv fylpsdsgek vtlcisilva ltvff l l lte iipatsislp ligkyllftm
241 vmvtlsvvvt vislnlhfr t ptthrmpewv kwlflkflpk vlfmrrplad tddtyr rvsq
301 r rgdncekva inyhehrvsr dieralstsp vder iqklyy spavvkafen vcfiaellkk
361 kdrddkvded wkyvamvldr lf l l lfsfac figtvtil lq aptlydrrea ndlqyrpani
421 stpvtq  
Figure 2.17. The amino acid sequence of the UNC-38 subunit in Ascaris 
suum. 
 
In the protein sequence database, the amino acid sequence (Figure 2.17) of 
an A. suum nAChR subunit is also available. This protein is 78% identical to the 
UNC-38 nAChR subunit in C. elegans. In EST library, a gene sequence that predicts 
to encode a UNC-38 subunit is also found in Ascaris lumbricoides. Although 
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information about the nAChR subunit is limited at the genetic and molecular level, 
our previous pharmacological and physiological studies in Ascaris suum indicated 
the existence of multiple subtypes. 
2.7.1. Pharmacological observations 
Using an Ascaris muscle contraction assay, three pharmacological types of 
nAChRs have been observed in Ascaris somatic muscle  (Robertson et al., 2002). 
All these types respond to acetylcholine and nicotinic agonists, such as nicotine, 
levamisole and bephenium. However, the sensitivities of the types to the agonists 
are different. According to the agonist sensitivity, we named them L-type 
(levamisole-sensitive), N-type (nicotine-sensitive) and B-type (bephenium-sensitive). 
The antagonists paraherquamide and 2-desoxoparaherquamide inhibit the muscle 
contraction induced by nicotinic agonists. The inhibitory effects are subtype selective 
and distinguishable with the competitive model. This evidence suggested the 
presence of multiple subtypes of nAChRs in Ascaris and different agonists and 
antagonists selectively target the different subtypes. 
2.7.2. Physiological observations 
The nicotine-sensitive (N-type) and levamisole-sensitive (L-type) nAChRs 
have also been observed at the single-single level (Levandoski et al., 2005). With 
the patch-clamp technique, individual ion channel properties were observed. When 
nAChRs located at the somatic muscle bind with nicotine or levamisole molecules, 
the associated ion channel was opened and the single-channel current was 
recorded. In these single-channel recordings, the channel conductance exhibited at 
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least two levels, one was ~25 pS and the other one was ~40 pS. It suggests that two 
nAChRs were observed. Further analysis indicates that nicotine is more selective for 
the small conductance nAChR and levamisole is more selective for the large 
conductance nAChR. The evidence implies that N-type and L-type nAChR were 
observed at the single-channel level. 
2.8. Nicotinic AChRs in C. elegans 
Nematodes have a large family of nAChR subunits. In the genome of C. 
elegans, 27 genes were identified to encode nAChR subunits. There are also more 
than 20 orphan genes that are predicted to encode nAChR subunits (Jones and 
Sattelle, 2004; Brown et al., 2006). The knockout mutants of most nAChR subunits 
are available to study the function and phenotypes. 
2.8.1. Receptor subunits in the genome 
The 27 subunits are classed into 5 groups, UNC-38-like, UNC-29-like, ACR-
16-like, DEG-3-like and ACR-8-like (Jones and Sattelle, 2004). The UNC-38-like 
group consists of three α subunits, UNC-63, ACR-6 and UNC-38, which are most 
similar to insect α subunits. The ACR-16-like group is highly homologous to the 
vertebrate α7 subunit and can form homomeric ion channels. The UNC-29-like group 
consists of four non-α subunits, ACR-2, 3, LEV-1 and UNC-29, which are similar to 
insect non-α and vertebrate skeletal muscle non-α subunits. The DEG-3-like and 
ACR-8-like groups appear to be unique in nematodes. 
 
 37
2.8.2. Levamisole receptor 
Levamisole is a nematode specific nAChR agonist. Treatment of nematodes 
with levamisole can induce spastic paralysis of the muscle cells and stimulation of 
egg laying (Lewis et al., 1980). Studies of levamisole-resistant mutants make it 
possible to identify the genes that affect the function of the levamisole receptor 
(Fleming et al., 1997). The knockout of any of unc-38, unc-63 and unc-29 leads to 
the loss of levamisole sensitivity. The knockout of either lev-1 or lev-8 leads to a 
partial loss of levamisole sensitivity. These observations indicate that the UNC-38, 
UNC-63 and UNC-29 subunits are essential subunits for the functional levamisole 
receptor. The LEV-1 and LEV-8 subunits also contribute to the levamisole receptor 
but may not be critical (Fleming et al., 1997). 
The properties of the levamisole receptor have also been studied using patch-
clamp. The whole-cell current induced by levamisole or acetylcholine was observed 
at the body wall muscle cell. In unc-38, unc-63 or unc-29 knockout mutants, the 
whole-cell current was abolished (Richmond and Jorgensen, 1999; Culetto et al., 
2004). In lev-1 mutants, the whole-cell current was reduced by ~90% (Culetto et al., 
2004). In lev-8 mutants, the whole-cell current was reduced by ~70% (Towers et al., 
2005). The function of levamisole receptors located at the neuromuscular junction 
have been reported to be involved in the body movement of nematodes, but the 
levamisole receptor null mutations only partially impair nematode movement. It is 
believed that other nAChR subtypes that are levamisole-insensitive are present at 
the neuromuscular junction, and also contribute to the excitatory neurotransmission 
between motor neurons and muscle cells. 
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2.8.3. Nicotine-sensitive nAChRs in C. elegans 
The nicotine-sensitive nAChR was observed in 1999 (Richmond and 
Jorgensen, 1999), but the molecular and genetic basis of this receptor remained 
unknown until 2005. It was found that there is a levamisole-insensitive nAChR 
subtype at the neuromuscular junction. Nicotine and acetylcholine, but not 
levamisole, are agonists of this receptor and induce whole-cell currents. When 
acetylcholine depolarizes the body wall muscle cell, the nicotine-sensitive receptor 
contributes most of the inward whole-cell current. With a microarray searching 
strategy, among more than 40 putative nicotinic receptor subunit genes in the C. 
elegans genome, it was identified that ACR-16 is the only essential subunit of the 
levamisole-resistant nicotinic receptor (Touroutine et al., 2005).  
2.9. Nicotinic AChRs in vertebrates 
In human, rat and chick, multiple genes that encode nAChR subunits have 
been identified. Based on their evolutionary, pharmacological and physiological 
profiles, the subunits encoded by these genes are grouped into three classes: 
muscle type subunits (α1, β1, δ, ε and γ), standard neuronal subunits (α2-α6 and β2-
β4) that form nAChRs in αβ combinations, and subunits (α7-α10) capable of forming 
homomeric nAChRs (Colquhoun & Patrick, 1997; Le Novere & Changeux, 1995; 
McGehee & Role, 1995).  
Muscle nAChRs found at the neuromuscular junction are made up of two α1, 
one β1, one ε and one γ subunit. In vertebrate nervous systems, the neuronal 
nAChRs have many diverse combinations according to an α2β3 stoichiometry with 
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the possibility of more than one α subunit type in one nicotinic receptor (Conroy et 
al., 1992). In addition, α7, α8 and α9 subunits are known to form functional homo-
oligomers (Couturier et al., 1990). However, heterologous expression of these 
subunits in Xenopus oocytes and mammalian cells has established certain rules to 
limit the subtypes of nAChRs that may functionally exist: (1) α2, α3 or α4 subunits 
can form functional nAChRs combining with β2 - β4; (2) The combination of only α5 
and β3 subunits cannot form functional nAChRs but they have to express with at 
least two other types of subunits (Lukas et al., 1999); (3) α6 subunits have been 
shown to form functional heteromeric nAChRs when co-expressed with β4 or at least 
two other types of subunits including β3 (Kuryatov et al., 2000); (4) α7, α8 and α9 
are distinguished by their ability to form homomeric nAChRs in expression systems 
(Couturier et al., 1990; Keyser et al., 1993; Elgoyhen et al., 1994; Gotti et al., 1994). 
Evidence indicates that the α7 subunit can also form more complex combinations 
(Yu and Role, 1998; Girod et al., 1999). 
In native systems, only a few major combinations of nAChRs have been 
identified. In the mammalian brain, most nAChRs contain either α4β2 or α7 subunits 
(Charpantier et al., 1998; Nashmi and Lester, 2006). The α4β2-containing nAChR is 
the major subtype existing in the central nervous system (CNS). Expression studies 
in Xenopus oocytes proposed the stoichiometry (α4)2(β2)3 (Cooper et al., 1991). 
However, other combinations may present in vivo (Lukas et al., 1999). Another 
major subtype of nAChRs presenting in CNS and peripheral nervous system is 
comprised of α7 subunits (Chen and Patrick, 1997). The α7 subunit is generally 
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thought to form homomeric nAChRs. But in the chick brain and retina, it has been 
reported that α7 subunits also combined with α8 subunits to form heteromeric 
subtypes (Keyser et al., 1993; Gotti et al., 1994; Yu and Role, 1998). The α8 
homomeric and heteromeric subtypes have been observed in avian brain and 
tissues (Couturier et al., 1990; Keyser et al., 1993; Elgoyhen et al., 1994). 
2.10. The regulation of nAChR functions by receptor associated 
proteins 
The function of ligand-gated ion channels is regulated by intracellular proteins, 
such as the stargazin protein required for normal action of glutamate receptors 
(Walker et al., 2006). SOL-1, another receptor associated protein, was recently 
found to regulate ionotropic glutamate receptor desensitization (Walker et al., 2006). 
Many proteins are also associated with nicotinic receptors (Gottschalk et al., 2005). 
The role of these proteins in receptor regulation is being studied. Here, two nAChR 
associated proteins are introduced. LEV-10 was found to be required for the 
receptor clustering. Another nAChR modulator recently has been found to regulate 
nAChR signal transduction. 
2.10.1. Nicotinic receptor clustering and LEV-10 protein in C. elegans 
LEV-10 was found to associate with the levamisole receptor in C. elegans 
(Gottschalk et al., 2005). The extracellular region of this protein has one LDL domain 
and five predicted CUB domains that may be involved in extracellular protein-protein 
interactions (Gally et al., 2004). A phenotype of weak levamisole- resistance was 
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observed in the lev-10 knockout mutant (Fleming et al., 1997). In N2 wild type 
worms, levamisole receptors aggregate at the postsynaptic neuromuscular junction. 
When the lev-10 gene is knocked out, the receptor cluster could not be detected with 
GFP labeling. However, the levamisole-induced whole-cell current remained similar 
to that in N2 animals. The evidence suggests that the receptor cluster diffuses but 
the receptor remains functional on the cell body. Due to this re-localization of 
nicotinic receptors, the synaptic cholinergic transmission is inefficient. In C. elegans, 
two nAChRs, levamisole-sensitive and nicotine-sensitive, are present at the 
neuromuscular junction. The LEV-10 protein is required for the clustering of the 
levamisole receptor but not the nicotine-sensitive receptor. Ongoing studies are 
investigating the clustering mechanism of LEV-10 (Gally et al., 2004). 
2.10.2. Receptor modulation proteins in C. elegans 
A novel mutant that showed partial levamisole resistance was recently 
isolated in Dr. Bessereau’s lab (pers. comm.). The gene associated with drug 
resistance was cloned. This gene encodes a transmembrane protein that seems to 
be synaptic in wild type animals. In mutants, levamisole receptor clusters were 
detected at the neuromuscular junction. It means that this protein is not required for 
receptor localization like LEV-10. Levamisole induced whole-cell currents were 
reduced by 50% compared to wild type, N2 animals. It is possible that this protein is 
directly modulating the activity of nAChRs, like the stargazin and SOL-1 proteins for 
glutamate receptors. 
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2.11. Anthelmintics: levamisole and paraherquamide 
Nicotinic agonists, including levamisole, pyrantel, and morantel, are one of 
the major types of anthelmintic used to treat both adult and larval nematode 
infections of domestic animals. These compounds have been reported to cause 
depolarization and contraction of nematode muscle and produce spastic paralysis of 
parasites (Aceves et al., 1970; Aubry et al., 1970). Levamisole, pyrantel, and 
morantel act as agonists of nACh receptors on the muscle bag membranes of 
Ascaris suum. The relative potencies of levamisole, pyrantel and morantel have 
been determined from concentration-conductance relationships on whole cells and 
found to be: morantel = pyrantel > levamisole > ACh (Harrow and Gration, 1985). 
These compounds also act as cholinergic receptor agonists in other invertebrates 
and vertebrates. The relative potencies of the drugs are different for receptors in the 
different species (Eyre, 1970). Paraherquamide is a novel anthelmintic, which was 
observed to induce flaccid paralysis of nematodes. The published data suggests that 
it behaves as a competitive antagonist of nicotinic acetylcholine receptors 
(Robertson et al., 2002). 
2.11.1. Levamisole 
Levamisole is (-)-2,3,5,6-tetrahydro-6-phenylimidazo[2,1-b]thiazole (Figure 
2.18). Following oral administration in sheep and goats, levamisole is rapidly 
absorbed from the gastrointestinal tract and gives excellent results against both 
adults and larvae of most nematodes (Renoux, 1980). 
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Figure 2.18. Chemical structure of levamisole. Molecular Formula is 
C11H12N2S. Levamisole is a potent anthelmintic used to treat nematode 
infestation. This compound has been shown to act as an agonist of nACh 
receptors. 
After uptake of levamisole, there is an initial contraction followed by a 
paralysis of whole Ascaris (Aceves et al., 1970). Levamisole was found to induce an 
irreversible contraction that could not be inhibited by atropine, tubocurarine, 
hexamethonium or piperazine (Coles et al., 1974; Coles et al., 1975). This 
observation suggested that levamisole might act at ACh receptors without inducing 
the release of ACh. Using intracellular current- and voltage-clamp techniques, 
Harrow and Gration (1985) showed that levamisole acted at ACh receptors located 
on the muscle bag membrane of Ascaris suum causing an increase in input 
conductance and depolarization of the muscle cells. 
2.11.2. Paraherquamide 
Paraherquamide is an oxindole alkaloid metabolite of Penicillium paraherquii. The 
first isolation of paraherquamide was back in 1981 (Yamazaki et al., 1981). 
Subsequently, Shoop (1990) detected the anthelmintic activity of paraherquamide. 
Paraherquamide is effective against strains of parasites that are resistant to the 
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known broad-spectrum anthelmintic drugs (Shoop et al., 1990; Shoop et al., 1991; 
Shoop et al., 1992). The paraherquamide family consists of a group of analogues 
(paraherquamide A-G); among them paraherquamide A ( 
Figure 2.19) is most active. Recently, some research groups including 
Phamacia Upjohn investigated other new analogues, one of which, 2-
desoxoparaherquamide was chosen for further study. Zinser et al. (2002) observed 
that paraherquamide and 2-desoxoparaherquamide applied in vitro induced flaccid 
paralysis of nematode somatic muscle without affecting ATP levels. Another 
research group also reported that these two compounds behaved as competitive 
antagonists of nAChRs in the nematode Ascaris suum (Robertson et al., 2002). 
 
Figure 2.19. (Duplicated from Robertson et al., 2002) The chemical structure of the 
paraherquamide A. The O* is missing in 2-desoxyparaherquamide. 
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2.12. Drug resistance in parasitic nematodes 
Anthelmintic drugs are used to treat parasitic nematode diseases in humans 
and domestic animals. Currently there are three major classes of anthelmintics on 
the market. Avermectins, such as ivermectin, target glutamate-gated and GABA-
gated chloride channels. Ivermectin is effective against most intestinal worms, most 
mites and some lice (Hotson, 1982). Nicotinic agonists, such as levamisole and 
bephenium, target nicotinic acetylcholine receptors. Benzimidazoles, such as 
albendazole, bind to β-tubulins and inhibit the polymerization of tubulin to form 
microtubules (Lubega and Prichard, 1991). 
The repeated intake of one anthelmintic compound will lead to resistance in 
the parasite population and resistance is inherited (Prichard et al., 1980). It is 
believed when one nematode population is resistant to one anthelmintic compound, 
they may also be resistant to other members of the same chemical class. It is also 
possible that one population develops multiple resistance to several chemical 
classes (Wolstenholme et al., 2004). Mechanisms of the development of resistance 
are varied. It may due to the loss of the drug target, the change in the molecular 
structure or the change in localization of the drug target. It also may be due to 
changes in the metabolism of the drug. 
In my studies, I focused on the action of levamisole and levamisole resistance 
in nematodes. Levamisole acts as a cholinergic agonist. When levamisole molecules 
bind with the nicotinic acetylcholine receptor, the ion channel associated with the 
receptor is opened and induces cell depolarization. The depolarization of the body 
wall muscle cell leads to contraction and spastic paralysis of the animal (Aceves et 
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al., 1970). As with any other anthelmintic, the repeated intake of levamisole will lead 
to levamisole resistance in parasitic nematodes. The pharmacological and 
physiological studies of levamisole resistance in parasitic nematodes indicate that 
resistance is in part due to the diversity of nAChR subtypes (Robertson et al., 1999). 
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Chapter 3. Pharmacology of N-, L-, and B-subtypes of 
nematode nAChR resolved at the single-channel level in 
Ascaris suum 
Modified from a paper to be published in FASEB Journal (Qian et al., 2006) 
Hai Qian2, Richard Martin3,4 and Alan Robertson4 
1Reprinted with permission of FASEB Journal, 2006, 20(14), 2606-8, Epub 2006 Oct. 
20 
2Graduate student & primary author 
3Author for correspondence 
4These authors contributed equally to this work 
3.1. Abstract 
Pharmacological experiments on Ascaris suum have demonstrated the 
presence of three (N-, L-, and B-) subtypes of cholinergic receptor mediating 
contraction of body wall muscle in parasitic nematodes (Robertson et al., 2002). In 
the present study, these ionotropic acetylcholine (ACh) receptors (nAChRs) were 
activated by levamisole and bephenium under patch-clamp conditions and 
competitively antagonized by paraherquamide and 2-desoxoparaherquamide. A 
number of recordings exhibited three separate current amplitude levels, indicating 
the presence of small, intermediate, and large conductance subtypes of receptor. 
The mean conductance of the small conductance subtype, G25, was 22 ± 1 pS; the 
intermediate conductance channel, G35, was 33 ± 1 pS; and the large conductance 
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channel, G45, was 45 ± 1 pS. The small channel was not antagonized significantly by 
paraherquamide and was identified as the N-subtype. The intermediate channel was 
preferentially activated by levamisole rather than bephenium and antagonized by 
paraherquamide: the intermediate channel was identified as the L-subtype. The 
large conductance channel was preferentially activated by bephenium, antagonized 
more by 2-desoxoparaherquamde than by paraherquamide and was identified as the 
B-subtype. These observations reveal that the three channel subtypes have different 
selectivity for cholinergic anthelmintics. The different selectivity of these compounds 
should be considered when dealing with drug resistant infections. 
3.2. Introduction 
Over one-third of the human population is infected with intestinal parasites. In 
a World Health Organization report (WHO, 2000) , it was observed that 17.3 million 
deaths, of the global total of 52.2 million deaths, were due to infectious and parasitic 
diseases. A common nematode parasitic disease of humans is ascariasis, which has 
a prevalence of 30–60% in endemic areas, producing symptoms of malnutrition, 
retardation of growth in children, diarrhea, and abdominal pain and in a smaller 
proportion of cases, death (Holland et al., 1989). Gastrointestinal nematodes are the 
major cause of morbidity in schoolchildren when measured in disability adjusted life 
years (DALYs). Levamisole is a representative of an important group of anthelmintic 
drugs (including pyrantel) that is used for treatment of ascariasis as well as other 
human nematode parasite infections (Horton, 2003). Members of this group act 
rapidly by selectively gating pharmacologically distinctive ionotropic (nicotinic) ACh 
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receptor ion-channels (nAChR) on the body muscles of nematodes (Robertson and 
Martin, 1993; Martin et al., 1998). 
Human studies show that anthelmintic treatment with cholinergic 
anthelmintics and other anthelmintics is <100% effective. Albonico et al. (Albonico et 
al., 2002) described the efficacy of cholinergic anthelmintics against Ascaris sp. 
(roundworm), Trichuris sp. (whipworm) and Ancylostoma sp. (hookworm). The cure 
rates for these parasite species is <100%. A proportion of parasites is innately 
resistant and unaffected by treatment. The regular use of anthelmintics produces a 
Darwinian selection pressure that increases the proportion of resistant individuals in 
the population (acquired resistance). This has been well established for nematode 
parasites of domestic animals. More recently, significant resistance of human 
parasites to cholinergic anthelmintics has been described making the drugs 
ineffective (Reynoldson et al., 1997; Sacko et al., 1999). The prospect for the 
development of new anthelmintics is very limited, so there is an urgent need to 
investigate the mechanisms of anthelmintic resistance and to find new ways to 
counter resistance. 
We have focused on sites of action of the cholinergic anthelmintics to gain a 
better understanding of their modes of action and mechanisms of resistance. In 
contraction assays using muscle strips from the parasitic nematode Ascaris suum, 
we have observed that there are pharmacologically distinct nAChRs that can be 
activated by the different cholinergic anthelmintics (Robertson et al., 2002). We were 
able to separate three types of nAChR: the N-subtype that is preferentially activated 
by nicotine; the L-subtype that is preferentially activated by levamisole and 
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antagonized by paraherquamide; and the B-subtype that is preferentially activated 
by bephenium and antagonized by paraherquamide and 2-desoxoparaherquamide. 
Our studies also found that levamisole resistance is associated with a loss of 
sensitivity of the L-subtype receptors with no loss in the sensitivity of the N-subtype 
of receptors (Martin et al., 2003; Martin et al., 2004). These observations suggest 
that N-type and B-type selective cholinergic agonists may be useful for overcoming 
some types of levamisole resistance. 
In addition to the muscle contraction assays, we have also compared the 
effects of nicotine and levamisole under patch clamp (Levandoski et al., 2005) to test 
our hypothesis that the selectivity of these two ligands is different. We found that 
both nicotine- and levamisole-activated channels had a wide and overlapping 
conductance range but that nicotine preferentially activates smaller, 26 pS, channels 
and that levamisole preferentially activates another, 39 pS, group of channels. In this 
study, we are able to separate out a third subtype to compare the effects of 
levamisole and bephenium at the single-channel level and test the effects of the 
novel competitive-antagonists paraherquamide and 2-desoxoparaherquamide 
(Yamazaki et al., 1981; Robertson et al., 1999; Zinser et al., 2002). We were thereby 
able to identify the single-channel properties of the N-, L-, and B-receptors. These 
observations are notable because they emphasize the different selectivity of the 
different cholinergic anthelmintics between the different subtypes of cholinergic 
receptor. This means, for example, that loss of the L-subtype with levamisole 
resistance (Robertson et al., 1999; Martin et al., 2004) might be overcome by using 
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other cholinergic agonists (methyridine: N-subtype) or antagonists (2-
desoxoparaherquamide; B-subtype) with selectivity for other subtypes of nAChR. 
3.3. Materials and methods 
3.3.1. Maintenance of Ascaris suum 
Adult Ascaris suum were collected from the IBP Meat Packing Plant (Storm 
Lake, IA). The worms were maintained at 32°C in Locke’s solution (changed daily) 
for no longer than 5 days. Locke’s solution contains (mM): NaCl, 155; KCl, 5; CaCl2, 
2; NaHCO3, 1.5; D-glucose, 5. Mature, active Ascaris suum ~10–20 cm in length 
were selected for experiments. 
3.3.2. Vesicle Preparation 
The muscle membrane vesicle preparation has been described previously 
(Robertson and Martin, 1993) and is briefly outlined here. The Ascaris were 
dissected and a muscle flap was prepared and pinned cuticle side down onto a 
plastic dish lined with Sylgard. The muscle flap preparation was washed with 
maintenance solution to remove fragments of the gut. The maintenance solution 
contains (mM): NaCl 35, NaAc 105, KCl 2, MgCl2 2, HEPES 10, glucose 3, L-
ascorbic acid 2, EGTA 1. The maintenance solution was then replaced with 
collagenase solution containing (mM):  NaCl 35, NaAc 105, KCl 2, MgCl2 2, HEPES 
10, glucose 3, L-ascorbic acid 2, collagenase 1mg/ml. After collagenase treatment 
for 4–8 min at 37°C, the muscle preparation was washed and incubated at 37°C. 
Small membranous vesicles, 10–50 µm in diameter, grew out from the membrane of 
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the muscle cells. These membranous vesicles were transferred to a recording 
chamber. 
3.3.3. Electrophysiology 
The maintenance solution in the chamber was replaced with bath solution. To 
block potassium channels present in muscle cells, the bath solution contains high 
concentration Cs+ (mM): CsCl, 35; Cs acetate, 105; MgCl2, 2; HEPES, 10; EGTA, 1; 
pH 7.2 with CsOH, at room temperature. The vesicle preparation was used within 3h. 
The patch-clamp technique was used to record the single-channel currents 
activated by levamisole or bephenium from the vesicle preparation. The pipettes 
were filled with pipette solution that contained (mM): CsCl, 140; MgCl2, 2; HEPES, 
10; EGTA, 1; pH 7.2 with CsOH. Pipettes with resistances of 3–5 MΩ (Hamill et al., 
1981) were used. The current signal was amplified by an Axopatch 200B amplifier 
(Axon Instruments, Union City, CA) filtered at 2 kHz (3-pole Bessel) and then 
sampled at 25 kHz digitized with a Digidata 1320A (Axon Instruments) and stored on 
a computer hard disk. 
3.3.4. Data analysis 
Data were idealized and analyzed using pCLAMP Ver 8.2 software (Axon 
Instruments). The generally low level of channel opening produced extremely rare 
multiple opening events; these were omitted from calculations of Popen and mean 
open time. The current amplitude histograms were fitted with the sum of one, two, 
and three Gaussian equation to determine the mean current amplitudes of the 
channel openings. The best Gaussian fits (confidence level > 0.95) were used to 
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help determine the number of amplitude populations present in one patch. This 
analysis and curve fitting were done using pCLAMP 8.2 and Prism V4 (GraphPad 
Software, San Diego, CA). To fit the distribution of the all the individual levamisole 
channel conductances, we used a simplex method to minimize the residual sum of 
squares with the aid of the NAG subroutine E040CCF to fit the sum of three 
Gaussian distributions (Robertson et al., 1999) and were able to obtain estimates of 
the areas, mean conductance, and SD of the three populations. 
We measured Popen as the patch-Popen (the proportion of time channels in the 
patch were open during the recording). Results are mean ± SE and were tested for 
normality. Although the distribution of open times were exponential, we found that 
the distributions of the means of open times from different patches did not deviate 
significantly from normality so differences between three groups of means was 
tested by ANOVA and differences between two means were evaluated using a t-test. 
3.3.5. Drugs 
Paraherquamide and 2-desoxoparaherquamide were obtained from Pfizer 
Animal Health (Kalamazoo, MI). Other drugs and chemicals were purchased from 
Sigma Chemical Co (St. Louis, MO). Paraherquamide or 2-desoxoparaherquamide, 
dissolved in dimethyl sulfoxide (DMSO), was added to the bath solution to give final 
concentrations of 0.3–10 µM. The concentration of DMSO in bath was always < 
0.3%. Levamisole or bephenium was present in the pipette solution to activate the 
channels. 
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3.4. Results 
3.4.1. Levamisole activated conductance of three different channels 
When levamisole (30 µM) was used as the agonist in the pipette solution, 
single-channel currents (Figure 3.1A) with a conductance of 18–53 pS and mean 
open times of 0.2 – 2 ms were observed at membrane potentials of ±75 and ±50 mV 
from inside-out patches. These channels were never recorded in the absence of 
levamisole. To confirm that these single-channel currents were indeed activated by 
levamisole, a series of alternating patch recordings was made from the same 
"active" vesicle: first with, and then without, levamisole present in the pipette solution. 
In six such paired recordings, channels were recorded in the presence of levamisole 
but not in the absence of levamisole. On four occasions, a third patch recording was 
made from the same "active" vesicle with pipette solution again containing 
levamisole. Under these conditions, characteristic single-channel currents were 
observed in all four of four patches. These observations confirmed that the currents 
were activated by levamisole. 
In each patch, levamisole activated up to three populations of channel 
currents that were clearly separated by differences in their conductance. Figure 3.1A 
shows some representative channel openings at +75 mV in a single patch recording 
and the amplitude histogram that was fitted by the sum of three Gaussian 
distributions with mean currents of 2.0, 2.7, and 3.6 pA. In all experiments where 
three or more voltages were tested between +75 mV and –75mV, it was found that 
the current-voltage relationships of the channels were linear. In some experiments 
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where only two potentials were available, it was also taken that the relationship was 
linear. We determined conductance from the slopes of the current-voltage plots 
using linear regression. In Figure 3.1B the channels had a conductance of 26, 36, 
and 48 pS. 
We recorded levamisole-activated currents from 58 such channels from 38 
patches: 22 had only 1 conductance level present, 12 had 2 conductance levels 
present, and 4 had 3 conductance levels present. The conductance ranged from 18 
to 53 pS. The wide range of conductance values coupled with the low error 
associated with the measurement of individual channel conductance (SE ≤3 pS, r2 
>0.95 with currents measured at 3 or more potentials) made it unlikely that there was 
only a single population of channels present. Since the experimental conditions were 
equal over an individual patch, the presence of the three types of conductance in 
single patches revealed the presence of separate and distinctive small-, 
intermediate-, and large-conductance channel populations. To determine the 
conductance ranges of the three populations, we determined the mean and 95% 
confidence intervals of the small, intermediate and large conductance populations 
from the 4 patches showing the three types of conductance (Table 3.1). The 
confidence limits for the small, 22 pS, channels were 17.8 and 26.3 pS; the 
confidence limits for the intermediate, 32.7 pS, channels were 26.5 and 38.9pS; and 
the confidence limits for the large, 42.9 pS, channels were 36.6 and 49.3 pS. 
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Figure 3.1. Three levamisole-activated channel currents from a single patch. 
A, top) Single-channel openings from a single patch recording at +75 mV 
showing 3 separate channel currents: O1, O2, and O3 are open levels, 
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and C is closed level. A, bottom) Current amplitude histogram of patch 
recording best fitted by sum of 3 Gaussian distributions: peaks are 2.12 ± 
1.47, 2.84 ± 0.05, and 3.83 ± 0.01 pA (mean ± SE). B) Current-voltage 
plots of conductance of 3 separate channels: linear regression was used 
to determine slope conductance: 26 ± 1, 36 ± 0, and 48 ± 1 pS (means ± 
SE). The 26 pS channel was not well resolved at –75 mV. 
 
Next, we classified the remaining channel conductance in the other single or 
double channel patches into three populations according to their conductance using 
the 95% confidence intervals determined in the three channel patches. Channels 
classified as small all had a conductance of <26.5 pS; channels classified as 
intermediate had a conductance of 26.5–36.6 pS; and channels classified as large 
had a conductance of >38.9 pS. Only two types of conductance that had values 
between 36.6 and 38.9 could not be classified and were excluded in the following 
analysis. 
 
Table 3.1. Conductance ranges and mean values of 3 populations for all 
patches. 
Small G25 Intermediate G35 Large G45
Levamisole (30 µM) Range 18 - 27 28 - 36 39 - 52
Mean ± SE 23 ± 1 33 ± 1 45 ± 1
N (number of channels) 15 22 19
Bephenium (1 µM) Range - 31 - 40 42 - 49
mean ± SE - 36 ± 1 43 ± 1
N (number of channels) - 10 16  
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For 30 µM levamisole experiments, 3 populations, G25, G35, and G45, were 
observed. For 1 µM bephenium, 2 populations, G35 and G45 were 
observed. 
 
Table 3.1 shows that the mean ± SE of the conductance for all the small 
channels was 23 ± 1 pS (n = 15), and for convenience we refer to this channel as 
G25. The mean ± SE of the conductance for all the intermediate channels was 33 ± 1 
pS (n=22), and we refer to this channel population as G35. The mean ± SE of the 
conductance for all the large channels was 45 ± 1 pS (n=19), and we refer to this 
channel as G45. 
3.4.2. Levamisole preferentially activates G35 channels 
The confidence interval method showed that levamisole preferentially 
activated G35 channels over the other subtypes: 27% of the channels were G25 (15 
of 56), 39% were G35 (22 of 56), and 34% were G45 (19 of 56). To estimate the 
proportion of each subtype present using another approach, we fitted the 
conductance histogram of all 58 channels activated by levamisole to the sum of 
three Gaussian distributions using the individual 58 conductance values and an 
iterative simplex method (58; Figure 3.2A); 28% of these channels were G25 
channels with a mean ± SD of 24.5 ± 4.3 pS; 58% of the channels were G35 with a 
mean ± SD of 36.7 ± 5.3 pS; and 14% were G45 with a mean ± SD of 49.9 ± 1.6 pS. 
Both analytical approaches separated the channel subtypes and showed that 
levamisole activates more G35 channels than the other receptor channel subtypes. 
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The average conductance of the G35 channels is close to channels identified as the 
L-subtype of receptor and the conductance of the G25 channels is the same as N-
subtype of nAChRs (Levandoski et al., 2005). 
 
 
Figure 3.2. Frequency histogram of individual conductance of 58 channels 
activated by 30 µM levamisole. The histogram was fitted by the sum of 3 
Gaussian distributions using a simplex method to minimize residual sum 
of squares; 28% of these channels were G25 channels with a mean ± 
SD of 24.5 ± 4.3 pS; 58% of channels were G35 with a mean ± SD of 
36.7 ± 5.3 pS; and 14% were G45 with a mean ± SD of 49.9 ± 1.6 pS. 
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3.4.3. Bephenium activates only G35 and G45 channels 
When levamisole in the pipette solution was replaced by 1 or 10 µM 
bephenium (a cholinomimetic anthelmintic), only two channel types, G35 and G45, 
were observed in the patches. Bephenium did not activate the G25 channels. In 7 of 
the 19 patches with 1 µM bephenium in the pipette, G35 and G45 were recorded 
simultaneously; in the other patches (12 in 19 patches), only the G35 or G45 channel 
was present. The conductance range of all these channels was from 31 to 49 pS. 
Using the same approach that we used for the levamisole-activated channel currents, 
we again evaluated the mean conductance and 95% confidence intervals for the G35 
and G45 channels. From the two channel recordings in the seven patches, we found 
that the G35 channel had a 95% confidence interval of 31.6–40.2 pS and the G45 
channel had a 95% confidence interval of 41.6–47.1 pS. We used this information to 
sort the conductance of the single channel patches: conductance <40.2 pS was 
classified as G35 channels; channels greater than 41.6 pS was classified as G45 
conductance channels. Overall we found that the G35 channels activated by 
bephenium had a conductance of 36 ± 1 pS (mean ± SE; n=10). We found that the 
conductance of the G45 activated by bephenium had a conductance of 43 ± 1 pS 
(mean ± SE; n=16). The means and the conductance ranges of these two 
bephenium-activated populations are similar to those of the G35 and G45 channels 
activated by levamisole. 
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3.4.4. Bephenium activates more G45 than G35 channels 
The confidence interval method revealed that when 1 µM bephenium was the 
agonist 38% of the channel population was G35 (10 of 26) and 62% was G45 (16 of 
26). When the agonist was 10 µM bephenium, the proportion of G35 channels was 
42% (8 of 19) and the proportion of G45 channels was 58% (11 of 19). Thus 
bephenium activated more G45 channels than G35 channels, suggesting that these 
channels represent the B-subtype of receptors (Robertson et al., 2002). 
3.4.5. Different subtypes have different mean open-times 
Once we had separated the channels activated by 30 µM levamisole into G25 
G35, and G45, we were able to determine their mean open times by fitting a single 
exponential distribution to events >0.5 ms. We set the patch potential to +75 mV for 
these observations to minimize open channel block. In multiple conductance patches, 
each channel opening was separated into G25, G35, and G45 and their mean open 
times determined separately. An example of the three open time histograms from 
one patch is shown in Figure 3.3A. The G25 population had the shortest mean open 
times, and the G45 population had the longest mean open times. The G25 population 
had a mean open time of 0.6 ± 0.1 ms (mean ± SE; n=14); the mean open time of 
the G35 population was 0.8 ± 0.1 ms (mean ± SE; n=18); and the mean open time of 
the G45 population was 1.2 ± 0.1 ms (mean ± SE; n=17). The distributions of the 
mean open times of the three populations were not significantly different from a 
normal distribution. ANOVA was used to test the difference between the three (G25 
G35, G45) groups and significance was found (F=8.9, df 2, P<0.005). A t-test was 
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used to test the differences between the means of the G25 and G35 groups (P < 0.03), 
the means of the G35, and G45 (P <0.03), and the means of the G25 and G45 groups 
(P < 0.001): they were all significant (Figure 3.3C). 
A similar difference between the G35 and G45 channels was observed when 
bephenium was the agonist, Figure 3.3B. The mean open times of the G35 channels 
activated by 1 µM bephenium was 1.1 ± 0.2 ms (mean ± SE; n = 7), and this was 
significantly (P < 0.05) shorter than the mean open time of the G45 population that 
was 2.4 ± 0.2 ms (mean ± SE; n = 11) when tested with a t test, Figure 3.3C. The 
differences between the mean open times of the different conductance populations 
are consistent with these channel populations belonging to separable distinctive 
subtypes groups and not being a single continuum. 
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Figure 3.3. The mean open-times of the three channel populations were 
significantly different.  A) Representative open time histograms of 
distributions of G25, G35, and G45 channels activated by 30 µM 
levamisole at +75mV. Note that G25 have briefer openings than G35, 
which in turn are briefer than G45. B) Representative open time 
histograms of distributions of G35 and G45 channels activated by 1 µM 
bephenium at +75mV. Note that G35 have briefer openings than G45. C) 
Bar chart of mean open times of the G25, G35, and G45 of channels 
activated by levamisole and bephenium showing mean ± SE differences 
and the significance levels (*p < 0.05; **p < 0.01; ***p < 0.001). 
 
3.4.6. Bath application of paraherquamide inhibits the opening of nAChRs 
Our earlier muscle contraction experiments have demonstrated that 
paraherquamide is a competitive antagonist (Robertson et al., 2002). It is not 
possible to make outside-out patch recordings from the Ascaris muscle vesicles 
because they are under internal pressure and burst when whole-cell recordings are 
attempted. Fortunately, paraherquamide is lipid soluble and passes from the bath 
through inside-out patches to reach the extracellular receptor to act as an antagonist 
(Figure 3.4A). This is a technique that we have established and used for the 
application of lipid soluble ligands (Robertson and Martin, 1993; Levandoski et al., 
2005). Here we measured and normalized the antagonism using paired patches. We 
recorded from two patches and measured the Popen values using the same protocol 
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and time course to control for any rundown or effects of adding solution to the inner 
membrane. In the first control inside-out patch with channels activated by 30 µM 
levamisole in the pipette, we tested the effect of adding antagonist-free solution to 
the bath; there was sometimes a small decrease in Popen in the control patch. In the 
second test patch, with channels also activated by 30 µM levamisole in the pipette, 
we observed the effect on channel opening of adding paraherquamide to the bath. 
As a normalized measure of inhibition, the percent change in Popen produced by 
paraherquamide was divided by the percent change in Popen produced by the 
antagonist-free solution. 
The inhibitory effect of paraherquamide was dose dependent (Figure 3.4B ) 
and was described by the logistic function with an IC50 of 3.1 µM. Thus, we 
established that paraherquamide produced a dose-dependent antagonism of 
levamisole-activated channels. 
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Figure 3.4. Paraherquamide inhibition of 30 µM levamisole-activated 
channels in inside-out patches. A) Low time and higher time resolution of 
an inside-out patch recordings at +75mV showing patch recording before 
the bath-application of 10 µM paraherquamide and after application. 
Note marked reduction in Popen channel. B) Normalized Popen (NPo) 
paraherquamide (XB) concentration-response plot. 
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DMSOPDMSObeforeP
XbeforePXP
NPo
openopen
BopenBopen=  To determine NPo, the normalized patch 
Popen in the presence of paraherquamide [Popen(XB)] was divided by the 
patch Popen before the application of paraherquamide [Popen(before XB)]; 
this ratio was then normalized by dividing by the ratio [Popen (before 
DMSO)/Popen (DMSO)] obtained from the DMSO control patch (see 
Materials and Methods). n, the number of patches, was 4 or greater for 
each concentration. Line was fitted using a logistic function: Where NPmin 
is the bottom of the plateau; NPmax is top of plateau; and IC50 is 
paraherquamide concentration producing 50% inhibition. IC50 = 3.1 µM. 
 
3.4.7. Paraherquamide has no effect on channel conductance or mean open-
times 
Figure 3.5A and B, left, shows the representative effects of paraherquamide 
on channel conductance. It illustrates results from a patch at +75 mV with three 
channels (G25, G35, G45) activated by 30 µM levamisole in the pipette before (Figure 
3.5A) and after (Figure 3.5B) the addition of 1µM paraherquamide to the bath. The 
figure shows that the mean amplitude of each of the channels with a conductance of 
27 pS, 37 pS, and 47 pS is the same before and after the addition of 
paraherquamide. Interestingly, Figure 3.5 also shows that although the amplitude of 
each of the three channels is unchanged by paraherquamide, the overall frequency 
of the events is reduced due to the inhibitory action of paraherquamide. In all patch 
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recordings, we found no effect of paraherquamide on the amplitudes of any of the 
channel subtypes. 
Figure 3.5A and B, right, illustrates representative effects of 1 µM 
paraherquamide (Figure 3.5A, control; Figure 3.5B, paraherquamide) on the open 
time distribution of levamisole activated channels. It shows the distributions of open 
times of G35 and G45 channels activated by 30 µM levamisole in the pipette at 
+75mV before and after the addition of paraherquamide to the bath. There was no 
decrease of in the mean open times of either of the channel subtypes. There was no 
evidence in this patch or in any of the G35 or G45 channels recordings, that 
paraherquamide reduced the mean open time of the channels. The lack of effect on 
channel conductance or on open time is consistent with the competitive mode of 
action of paraherquamide (Colquhoun and Sheridan, 1982; Robertson et al., 2002). 
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Figure 3.5. Effect of paraherquamide on current amplitude and mean open 
times of G25, G35, and G45 channels. A) Control 30 µM levamisole-
activated single-channel amplitudes (left) and mean open times of G35 
and G45 channels (center and right) from an inside-out patch at +75mV; 
current amplitude distributions show 3 channels before addition of 
paraherquamide from a 1 min recording showing number openings and 3 
populations with a mean conductance of 27 pS (G25), 37 pS (G35), and 
47 pS (G45). Channel amplitudes: G25 of 1.8 pA, G35 2.7 pA, and G45 3.7 
pA at +75 mV. B) Effect of 1 µM paraherquamide on the 30 µM 
levamisole-activated single-channel amplitudes (left) and mean open 
times of G35 and G45 channels (center and right); 4 min recording for 
levamisole current amplitude histogram. Note that paraherquamide 
reduced frequency of channel open so a longer-period recording was 
analyzed to collect enough channel open events to determine Popen. 
Popen of 27 pS (G25) population was 0.00027 in control and 0.00031 in 1 
µM paraherquamide (no inhibition); Popen of 37 pS (G35) population 
reduced from 0.00807 in control to 0.00545 (68% reduction) in 1 µM 
paraherquamide; and Popen of 47 pS (G45) population was reduced from 
0.04079 in control to 0.02010 (49% reduction) in the 1 µM 
paraherquamide. Channel amplitudes in the presence of 1 µM 
levamisole were G25, 1.8; G35, 2.7; and G45, 3.7pA: note that there was 
no change in channel amplitudes. G35 had a mean open time of 0.8 ms 
and G35 had a mean open time of 1.7 ms in the presence of 1 µM 
 
 71
paraherquamide: note that paraherquamide could produce a reduction in 
Popen without a reduction in mean open times. Thus, inhibitory effect of 
paraherquamide on Popen was not associated with a reduction in channel 
amplitude or mean open times. C) Selective inhibitory effects of 
paraherquamide and 2-desoxoparaherquamide are statistically different. 
Left) Bar chart of mean ± SE of normalized inhibition NP1NP0 by 1 µM 
paraherquamide of G25, G35, and G45 channels activated by 30 µM 
levamisole. Right) Normalized inhibition of 10 µM bephenium-activated 
channels by 3 µM 2-desoxyparaherquamide of G35 and G45 channels. 
NPo is the patch Popen before application of the antagonist; NPxB is patch 
Popen in the presence of antagonist. 1 µM paraherquamide had a 
significantly greater (p < 0.05, n=4, t test) effect on Popen of both G35 and 
G45 (67.7% inhibition and 68.2% inhibition respectively) compared to no 
effect on Popen of the G25 population. 2-desoxoparaherquamide inhibited 
opening of the G35 (73.3%, n=4) and G45 (36.4%, n=5) channel 
populations activated by 10 µM bephenium; the difference between the 
effects on the G35 and G45 population was significant, *p < 0.05, t test. 
 
3.4.8. Inhibitory effects of paraherquamide and 2-desoxoparaherquamide are 
selective and the % inhibition depends on the receptor subtype 
We have described the selective effects of paraherquamide and 2-
desoxoparaherquamide on different nAChR subtypes in muscle contraction 
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experiments (Robertson et al., 2002). To investigate whether these two compounds 
show selective effects on the G25, G35, and G45 populations at the single-channel 
level, we tested the inhibitory effects of 1 µM paraherquamide and 3 µM 2-
desoxoparaherquamide on the Popen of the G25, G35, and G45 channels. 
Figure 3.5C shows the effect of 1 µM paraherquamide on the three nAChR 
populations (G25, G35, and G45) observed in seven patches at +75mV when activated 
by 30 µM levamisole. When 1 µM paraherquamide was present in the bath, ANOVA 
showed that the opening of the three channel populations was inhibited by different 
amounts (F = 6.9, df = 2, P = 0.01). Figure 3.5C shows that 1 µM paraherquamide 
had no effect on the G25 population but had an inhibitory effect on the G35 and G45 
channels (% control value: G25 106.1 ± 25.4%; n = 5; G35 32.3 ± 10.0%, n = 5; and 
G45, 31.8 ± 7.0%, n = 5). A t test showed that the inhibition of the G35 and G45 
channel was significant when compared to the G25 channels (P < 0.05). The lack of 
effect on G25 channels is consistent with this channel population being the N-subtype 
because it is the least sensitive to paraherquamide (Robertson et al., 2002). The 
greater effect on the G35 and G45 channels is consistent with these channels 
belonging to the L- and B-subtype because paraherquamide is a more potent 
antagonist of these two subtypes than the N-subtype (Robertson et al., 2002). 
We also used 10 µM bephenium to activate the G35 and G45 channels without 
activating the G25 channels. Bephenium activated currents were recorded from 12 
inside-out patches and the inhibitory effects on Popen of bath-applied 3 µM 2-
desoxoparaherquamide on the G35 and G45 channels observed, Figure 3.5C. 2-
desoxoparaherquamide had a significantly greater inhibitory effect on the G45 
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population than the G35 population (%reduction Popen of G45: 26.7 ± 7.1, n = 5; 
%reduction in Popen of G35: 63.6 ± 11.4, n = 4, P < 0.05). The greater effect of 2-
desoxoparaherquamide on G45 channels is consistent with these channels being the 
B-subtype (Robertson et al., 2002) and the G35 channels being the L-subtype 
(Robertson et al., 2002). 
3.5. Discussion 
3.5.1. N-, L-, and B-subtypes identified at the single-channel level on body 
muscle 
We have observed in muscle strip contraction assays of Ascaris suum 
(Robertson et al., 2002) that the cholinergic anthelmintics activate three subtypes of 
receptors on body muscle and that paraherquamide and 2-desoxyparaherquamide 
are competitive antagonists. There is the N-subtype that is preferentially activated by 
nicotine but not antagonized by paraherquamide and 2-deoxyparaherquamide; there 
is the L-subtype that is preferentially activated by levamisole and antagonized by 
paraherquamide; and there is the B-subtype that is preferentially activated by 
bephenium and antagonized by paraherquamide as well as 2-
desoxoparaherquamide (Robertson et al., 2002). 
In a previous study (Levandoski et al., 2005) at the single channel level, 
comparison of the effects of nicotine and levamisole revealed that nicotine and 
levamisole could activate a wide range of conductance but that nicotine 
preferentially activated small 26 pS channels and that levamisole preferentially 
activated larger channels with a conductance averaging 39 pS. In this current study, 
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we have been able dissect out the third, G45, subtype at the single channel level 
(Figure 3.6). Also in this study we found that levamisole activated channels over a 
wide conductance range and that in some patches we could identify 3 separate 
channels that we refer to as G25, G35, and G45 with mean conductance around 25, 35, 
and 45pS respectively. Levamisole activated more G35 channels than the other two 
subtypes. Paraherquamide had no effect on the G25 channels but antagonized the 
G35 and G45 channels in a manner that was consistent with the G25 channels being 
the N-subtype not the L- or B-subtype (Robertson et al., 2002). 
When we used bephenium as the agonist, it did not activate the G25 channels 
but activated more G45 channels than G35 channels; furthermore, 2-
desoxoparaherquamide selectively inhibited the G45 channels. We found that 2-
desoxoparaherquamide is a more potent antagonist of the G45 channels than the G35 
pS channels and that 1 µM bephenium preferentially activated the G45 channels. 
These observations allowed us to identify and confirm that the G45 channel is the B-
subtype and that the L-subtype is the G35 channel. 2-desoxoparaherquamide is a 
more potent antagonist of the B-subtype than of the L-subtype (Robertson et al., 
2002). 
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Figure 3.6. Summary diagram of channel properties and pharmacology of 
the N-, L-, and B-subtypes of AChR receptor channel found on the 
muscle cell of Ascaris showing their mean conductance, mean open time, 
and selectivity of agonists and antagonists. 
 
In addition to separation of the subtypes by pharmacology and conductance, 
we found that there were significant differences in their mean open times with the N-
subtype (G25) having the briefest open time, 0.6mS; the L-subtype (G35) having an 
intermediate open time, 0.9 ms; and the B-subtype (G45) having the longest open 
time,1.3 ms, when levamisole was the agonist. These experiments have allowed us 
to identify the three subtypes of muscle nAChR at the single-channel level and to 
see their pharmacology at that level. The significance of the different subtypes of 
nAChR is discussed in the following paragraphs. 
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3.5.2. Recognition of separate nAChR subtypes in parasitic nematodes is 
therapeutically significant 
We have observed that L-subtype channels decrease in frequency on the 
body muscle of the nematode parasite Oesphagostomum dentatum (Robertson et 
al., 1999) and that levamisole resistant isolates of Oesophagostomum dentatum 
become less sensitive to levamisole (more selective for L-subtype channels) but that 
they remain sensitive to the N-subtype agonist methyridine (Martin et al., 2003). If 
levamisole resistance is due to the loss of the L-subtype of receptors, a useful 
therapeutic approach may be to use cholinergic agonists or antagonists that have 
selective effects against N- and B-subtypes to treat levamisole resistance. This 
suggests that 2-desoxoparaherquamide or, a combination of methyridine or oxantel 
(N-subtype selective) and bephenium may be useful for the treatment of some types 
of levamisole resistance. 
3.5.3. Heterogeneity of nematode nAChRs 
We have observed three separate subtypes in the parasitic nematode Ascaris 
suum, but what is the molecular basis of the heterogeneity? Much information on the 
structure and function of nematode AChRs has advanced with the study of C. 
elegans, a soil nematode that has been subjected to detailed genetic analysis. We 
are encouraged to use C. elegans as a model for the levamisole receptor of parasitic 
nematodes by molecular phylogenetic analysis (Kennedy and Harnett, 2001). C. 
elegans belongs to clade V as do many nematode parasites like O. dentatum, and 
there are strong similarities between the single-channel properties of levamisole 
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receptors of A. suum (clade III) and O. dentatum (Jones and Sattelle, 2004). In both 
nematodes, channel conductance subtypes between 20 – 50 pS are observed with 
conductance subtypes that include the G25, G35, and G45. In O. dentatum, however, 
we were able to separate a fourth G40 conductance subtype (Robertson et al., 1999). 
With the completion of the C. elegans genome project, the full size of the 
nematode AChR gene family was finally revealed. There are now a total of 27 AChR 
subunit genes which is bigger than in mammals (13 genes, and is the largest 
number of AChR subunit genes in a single species (Jones and Sattelle, 2004). 
Homology has allowed these 27 subunits to be divided into five groups named: 
DEG-3-like; ACR-16-like; ACR-8-like; UNC-38-like; and UNC-29-like. The UNC-29-
like subunits are non-α subunits and the remainders are mostly α subunits. If all 
combinations of α and non-α subunit were capable of forming functional AChRs, 
there could be over 25 (Robertson and Martin, 1993) or 14,348,907 receptor 
subtypes, but this is not likely. The molecular structures of levamisole UNC-38 
subunit homologues in the parasitic nematodes, Trichostrongylus colubriformis 
(Wiley et al., 1997) and Haemonchus contortus (Hoekstra et al., 1997), are ~90% 
identical to C. elegans, suggesting that information derived from the model 
nematode may be a useful guide for parasitic nematodes. With a large number of 
AChR subunits in C. elegans, it is not surprising that we also see heterogeneity in 
our experiments on parasitic nematodes. 
We can see the molecular potential for the heterogeneity, but what is the 
functional benefit of this extensive heterogeneity? If nematodes are like vertebrates, 
then the physiological reasons for the heterogeneity include a necessity to have 
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varying sensitivities to the agonist ACh, to vary desensitization, calcium permeability, 
and distributions in different cells (McGehee and Role, 1995). We know that 
expression of UNC-38, UNC-29, UNC-63, LEV-1, ACR-8, ACR 16, and ACR-13 
(=LEV-8) GFP-tagged protein subunits occurs in body muscle cells of C. elegans 
(Fleming et al., 1997; Richmond and Jorgensen, 1999; Culetto et al., 2004; 
Touroutine et al., 2005; Towers et al., 2005), but details of the stoichiometric 
arrangements of the subunits and total number of receptor subtypes remain to be 
determined. In our study, we demonstrate the presence of three subtypes of nAChR 
in muscle of parasitic nematodes, each with a different sensitivity to cholinergic 
anthelmintics. The identification of multiple receptor subtypes in parasites has 
several practical implications. Firstly, it may help understanding of how resistance to 
the cholinergic anthelmintics can arise: changes in the relative of proportion of each 
subtype (by up- or down-regulation) will alter the sensitivity of the parasite to a 
specific anthelmintic. Secondly, therapeutics may benefit: using combinations of 
compounds that activate all receptor subtypes could enhance cure rates. Finally, it is 
predicted that, in some instances, parasites resistant to one type of cholinomimetic 
will retain sensitivity to others (e.g., levamisole resistant parasites can remain 
sensitive to bephenium or methyridine), thus offering an alternative strategy to deal 
with resistance. 
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Chapter 4. The single-channel properties of levamisole-
sensitive nicotinic acetylcholine receptors in 
Caenorhabditis elegans adults 
4.1. Abstract 
Nicotinic acetylcholine receptors (nAChRs) are important for synaptic 
neurotransmission. The roles of nAChR subtypes in the transmission are dependent 
on their channel properties and affinity to acetylcholine. In the nematode C. elegans 
the levamisole-sensitive nAChR is involved in many worm behaviors such as 
locomotion, egg laying and mating. Here we report the single-channel properties and 
kinetics of the levamisole receptor present at the neuromuscular junction (NMJ). In 
wild type animals nAChRs mostly aggregate at the NMJ. LEV-10 is a 
transmembrane protein that causes levamisole receptor clustering at the 
neuromuscular junction. In lev-10 knockouts, functional levamisole receptors are 
dispersed over the muscle cell body and are accessible for study using the patch-
clamp technique. In this study, we present the first study of the single-channel 
properties of synaptic nAChRs in adult C. elegans. Acetylcholine and levamisole 
activated the receptor with a single-channel conductance of ~30 pS and brief mean 
open-time. At high concentrations levamisole also behaved as an open channel 
blocker. We also tested for another neuromuscular nAChR subtype that is sensitive 
to nicotine. However, in lev-10 mutants no nicotine-sensitive receptor was detected 
from the extrasynaptic region. It demonstrates that the LEV-10 protein is only 
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required for the clustering of levamisole-sensitive nAChRs but not nicotine-sensitive 
nAChRs. This provides an essential foundation for the understanding of synaptic 
transmission mediated by cholinergic receptors. 
4.2. Introduction 
Cholinergic neurotransmission mediated by nicotinic acetylcholine receptors 
(nAChRs) plays important roles in both vertebrates and invertebrates. In vertebrates, 
dysfunctions of certain subtypes of neuronal nAChRs lead to psychiatric disorders 
(Araki et al., 2002). The nAChRs at the neuromuscular junction in the free-living 
nematode Caenorhabditis elegans (C. elegans) share many similar characteristics 
with the neuronal nAChRs in vertebrates, including multiple subtypes. C. elegans is 
also a model for studies of nematode parasites. This organism has been used to 
discover anti-parasitic drugs and for studies of the mechanism of the drug action. 
The genome of C. elegans was completely sequenced, and the genetics of nAChR 
subunits was been studied extensively. However, due to the small size of the worm, 
the physiological properties of the receptor subtypes have not been investigated at 
the single-channel level. 
At least two nAChRs are present at the postsynaptic neuromuscular junction 
of C. elegans body wall muscles: one is sensitive to levamisole and another is 
sensitive to nicotine (Richmond and Jorgensen, 1999). To date, it is known that the 
levamisole receptor is composed of three essential subunits (UNC-63, UNC-38 and 
UNC-29) and two nonessential subunits (LEV-1 and LEV-8). Behavioral studies 
indicate that the knockout of any essential subunits leads to strong levamisole 
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resistance, and the knockout of either nonessential subunits leads to partial 
resistance. Whole-cell patch-clamp studies showed the absence of the levamisole 
receptor in loss-function mutants of unc-63, unc-38, or unc-29, while the whole-cell 
current of lev-1 mutants was reduced to ~15% and the current of lev-8 mutants was 
reduced to ~1/3 of the wild type. Compared with the nicotine-sensitive nAChR, the 
inward current through the levamisole-sensitive nAChR only contributes a small 
proportion of the whole-cell current induced by acetylcholine, but the knockout 
mutants exhibit significantly uncoordinated motor behavior (Fleming et al., 1997). 
That suggests the important physiological role of this receptor. 
Besides the nAChR subunits, some other proteins, such as LEV-10, may 
regulate levamisole resistance and synaptic transmission (Jones and Sattelle, 2004). 
LEV-10 is a transmembrane protein that associates with nAChRs in C. elegans. This 
protein has been shown to be required for the postsynaptic clustering of the 
levamisole receptor. When the lev-10 gene was knocked out, postsynaptic clustering 
could not be detected but the whole-cell levamisole-activated current was intact. It 
suggests that the functional levamisole-sensitive receptor remains in the cell 
membrane without post-synaptic aggregation (Gally et al., 2004). These 
observations give us the possibility that a large amount of levamisole-sensitive 
receptors could be detected on the extra-synaptic cell body. Based on this 
observation we decided, using the patch-clamp technique, to test the single-channel 
properties of the levamisole-sensitive nAChR on the cell bag of the body wall 
muscles. 
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Our previous studies showed that the single-channel recording technique 
could be used to investigate individual nAChR subtypes in nematodes (Robertson 
and Martin, 1993; Qian et al., 2006). The individual subtypes observed from body 
wall muscle cells of nematodes showed different drug kinetics, phosphorylation 
modulation and Ca2+ permeability (Levandoski et al., 2005; Martin et al., 2005; Qian 
et al., 2006). Here we present an initial single-channel investigation in adult C. 
elegans. The single-channel investigation along with genetic approaches will lead to 
major advances in our understanding of synaptic neurotransmission mediated by 
individual nAChR subtypes. 
4.3. Materials and Methods 
N2 and lev-10(x17) worms used in this work were provided by the 
Caenorhabditis Genetics Center, which is funded by the NIH National Center for 
Research Resources (NCRR). All worms were grown on agar seeded with 
Escherichia coli OP50 at 20oC using established methods (Brenner, 1974). 
4.3.1. Preparation 
Adult worms were transferred into a recording chamber filled with extracellular 
solution containing (mM): NaCl 23, NaAc 110, KCl 5, CaCl2 6, MgCl2 5, HEPES 5, D-
glucose 11 and sucrose 10. The pH of the solution was adjusted to 7.2 with NaOH. 
The osmolarity was adjusted to 330 mOsm with sucrose. The worms were 
immobilized onto a sylgard-coated coverslip with cyanoacrylate (GluSeal® 510K# 
K030574, Glustitch Inc.). The cuticle was incised to expose anterior body wall 
muscle cells. The preparation was cleaned and enzyme-treated with extracellular 
 
 84
solution containing 0.5 mg/ml collagenase. This preparation method was modified 
from previous studies (Richmond and Jorgensen, 1999). The enzyme treatment was 
applied for ~15 seconds. Then the collagenase solution was replaced by recording 
bath solution containing (mM): CsCl 35, CsAc 105, MgCl2 4, HEPES 10, EGTA 1 
and sucrose 25, pH 7.2 adjusted with CsOH, 330 mOsm. 
4.3.2. Single-channel recording 
The patch-clamp technique was used to record the single-channel currents 
activated by acetylcholine or levamisole from the C. elegans preparation. Fire-
polished patch pipettes were pulled from capillary glass (G85150T, Warner 
Instruments Inc., CT). To block K+ channels (Yuan et al., 2000; Yuan et al., 2003) 
that may present on the patched membrane, we filled the recording pipettes with 
high Cs+ solution that containing (mM):  CsCl 140, MgCl2 4; HEPES 10, EGTA 1 and 
sucrose 12, pH 7.2, 315 mOsm.  Pipettes with resistances of 4 - 6 MΩ were used. 
The 1 cm near the tip of the electrode was covered with Sylgard to reduce 
background noise and improve frequency responses. All recordings were made 
using isolated inside-out patches. Single-channel currents were recorded at 
membrane potentials between -100 and +100 mV. The current signal was amplified 
by an Axopatch 200B amplifier (Axon Instruments Inc., CA, USA) filtered at 5 kHz (3-
pole Bessel), and then sampled at 25 kHz digitized with a Digidata 1320A (Axon 
Instruments Inc., CA, USA) and stored on a computer hard disk. 
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4.3.3. Data analysis 
Raw data was digitally-filtered at 2 kHz and analyzed using pCLAMP 9 
software (Axon Instruments Inc., CA, USA). Histograms of the amplitude were fitted 
with Gaussian distributions. Histograms of the channel open-time and closed-time 
were fitted with exponential curves. All fittings were done in pCLAMP 9. All statistical 
analysis was done in Prism V4 (GraphPad software, Inc., San Diego, CA, USA). 
Results are presented as mean ± s.e.. Significant differences were determined by t-
test (p < 0.05). 
4.3.4. Drugs 
NaCl, NaAc, KCl, CaCl2 and MgCl2 were obtained from Fisher. All the other 
drugs were obtained from Sigma-Aldrich. 
4.4. Results 
4.4.1. Nicotinic acetylcholine receptors were observed on the membrane of 
body wall muscle cells in lev-10 mutants 
The neurotransmitter acetylcholine and nicotinic agonist levamisole activate 
multiple subtypes of nematode nAChRs (Richmond and Jorgensen, 1999; Martin et 
al., 2005; Qian et al., 2006). To investigate the single-channel properties of nAChRs 
at body wall muscle cells of C. elegans, first we used acetylcholine (30 µM) to detect 
receptor activity in N2 wild type animals. From 17 membrane patches, single-
channel currents of 3 receptors were observed – in other words, 18% of the 
membrane patches showed some nAChRs. The observation indicates that in wild 
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type worms most nAChRs are not accessible. This is consistent with published 
studies that have shown nAChRs aggregate at the neuromuscular junction (Gally et 
al., 2004). 
Because most nAChRs aggregate at the postsynaptic region of the 
neuromuscular junction where patch electrodes cannot access, we decided to use 
lev-10 mutants rather than N2 wild types for further investigation. Three 
concentrations (10, 30 and 100 µM) of acetylcholine and levamisole were used as 
agonists to activate nAChRs from lev-10 animals. Overall, 83% of patches exposed 
to acetylcholine and 91% of patches exposed to levamisole showed single-channel 
currents. 
To confirm that these single-channel currents were indeed activated by 
acetylcholine or levamisole, two series of tests were made. First, several patches 
were isolated from the same cells (cell number = 5). One of the patches was tested 
with agonist-free pipette solution as a control and the other patches were tested with 
acetylcholine. With agonist-free control solution, no channel current was observed (n 
= 5). With acetylcholine test solution, 8 channels were observed from 11 patches. 
We also added levamisole into the bath solution of agonist-free control recordings. 
Four channels were observed from five patches. This is consistent with the 
expectation that lipophilic levamisole crossed membrane patches and bound with 
the extracellular agonist-binding sites to activate nAChRs. We conclude that the 
channel currents under our recording conditions were due to the activity of nAChRs. 
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4.4.2. Levamisole and acetylcholine activated nAChRs with a conductance of 
~30 pS. 
The single-channel properties of the receptor was tested with acetylcholine 
and levamisole at the concentrations of 10, 30 and 100 µM. Usually the channel 
currents were recorded when the membrane potential was held at -100, -75, -50 and 
+50 mV. Figure 4.1 shows a single-channel recording at -75 mV. In good worm 
preparations the membrane potential of some recordings was also held at +75 and 
+100 mV (Figure 4.2B). The histogram of the current amplitude was fitted with 
Gaussian curves to evaluate the mean amplitude value (Figure 4.2A). 
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Figure 4.1. Acetylcholine and levamisole induced single-channel cation 
currents on body wall muscle cells. (a) In an agonist-free control 
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recording, no Cs+ current was observed from the isolated inside-out 
patch at membrane potential -75 mV. (b) After levamisole was added into 
the bath solution, inward cation currents were observed from the same 
membrane patch. This demonstrated that the currents were induced by 
levamisole. (c) A typical single-channel recording trace recorded with 30 
µM levamisole at -75 mV. 
 
At negative membrane potentials, the relationship between membrane 
potential and current amplitudes was fitted with linear regressions to give the 
channel conductance. We calculated the channel conductance between -100 and -
50 mV. When tested with acetylcholine, the conductances were 30.1 ± 1.1 (n = 6), 
31.3 ± 1.0 (n = 5) and 31.5 ± 0.99 pA (n = 5), respectively, at concentrations of 10, 
30 and 100 µM. When tested with levamisole, the conductances were 29.3 ± 0.7 (n 
= 8), 31.2 ± 1.2 (n = 5) and 28.9 ± 1.2 pA (n = 4), respectively, at concentrations of 
10, 30 and 100 µM (Figure 4.2C, Table 4.1). The mean reversal potential calculated 
from the linear regression was ~ 0 mV (mean = -1.1 ± 0.6 mV, n = 33). In our 
experimental conditions, symmetrical Cs+ in pipette and bath solutions, the reversal 
potential predicted by the Nernst Equation is 0 mV. At positive membrane potentials, 
the relationship between membrane potential and current amplitude was not fitted 
with linear regression, but showed rectified I-V characteristics (Figure 4.2B). 
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Figure 4.2. The single-channel conductance was calculated from the I-V plot. 
The channel current (I) was recorded at different membrane potentials (V) 
from -100 to +100 mV.  (a) The histogram of amplitude at each potential 
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was fitted with Gaussian distributions to determine the mean value. The 
example shown here was made at -75 mV. (b) The nAChR showed a 
rectified outward current at positive membrane potentials. The I-V 
relationship between -100 and -50 mV was fitted with linear regression, 
and the slope gave the single-channel conductance. The I-V plot of the 
sample recording in Figure 4.1c is shown here and the calculated 
conductance was 31.8 ± 0.3 pS. (c) Overall, the mean conductance of 
the ion channel was ~30 pS when acetylcholine or levamisole was used 
as agonist. 
 
Table 4.1. The single-channel properties of the levamisole-sensitive 
receptors recorded from the body wall muscle of C. elegans adults. 
10 30 100 10 30 100
30 ± 1 31 ± 1 31 ± 1 29 ± 1 31 ± 1 29 ± 1
(n = 6) (n = 5) (n = 5) (n = 8) (n = 5) (n = 4)
0.31 ± 0.03 0.44 ± 0.03 0.31 ± 0.04 0.36 ± 0.03 0.30 ± 0.02 0.20 ± 0.02
(n = 6) (n = 6) (n = 4) (n = 8) (n = 3) (n = 4)
1.4 ± 0.2 (20%)
15.7 ± 2.7 (50%) 26.1 ± 9.6 (50%) 19.7 ± 5.5 (60%) 41.2 ± 11.6 (50%) 29.4 ± 11.5 (50%) 14.8 ± 2.5 (50%)
73.5 ± 9.6 (50%) 121.3 ± 49.0 (50%) 76.6 ± 14.9 (40%) 177.4 ± 48.5 (50%) 95.2 ± 28.9 (50%) 94.4 ± 32.8 (30%)
(n = 6) (n = 6) (n = 4) (n = 8) (n = 3) (n = 4)
NPopen 0.002 0.007 0.006 0.002 0.003 0.005
τc (ms) 
and %
LEVAMISOLE (µM)ACETYLCHOLINE (µM)
τo (ms)
g (pS)
 
g is single-channel conductance, τo is mean open-time, τc is mean closed-
time, % is percentage of total area and NPopen is normalized Popen. 
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4.4.3. The mean open-time of the nAChR was significantly shortened at high 
concentrations of levamisole. 
To determine the mean open-time (τo) of the ion channel, the duration times of 
channel openings were sorted in histograms and the histograms were fitted with 
single exponential curves (Figure 4.3A). We set the patch potential to -75 mV for 
these observations to give good signal-noise ratio and membrane stability. When 
tested with acetylcholine, the mean open-times were 0.31 ± 0.03 (n = 6), 0.44 ± 0.03 
(n = 6) and 0.31 ± 0.04 ms (n = 4), respectively, at concentrations of 10, 30 and 100 
µM (Figure 4.3B, Table 4.1). When tested with levamisole, the mean open-times 
were 0.36 ± 0.03 (n = 8), 0.30 ± 0.02 (n = 3) and 0.20 ± 0.02 ms (n = 4), respectively, 
at concentrations of 10, 30 and 100 µM (Figure 4.3B, Table 4.1). Compared to the 
observations of the acetylcholine tests, the mean open-times of levamisole were 
significantly shorter at the concentrations of 30 and 100 µM. Furthermore, the mean 
open-time of 100 µM levamisole was also significantly shorter than that of 10 µM 
levamisole. These results indicated that the open time of the ion channel was 
decreased when the concentration of levamisole was increased. 
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Figure 4.3. The mean open-time of the nAChR at -75 mV. (a) The open-time 
distribution was fitted with a single exponential equation to estimate the 
mean open-time τo. According to our experimental resolution, the dwell 
 
 94
times shorter than 0.2 ms were ignored. The sample recording showed 
here was tested with 30 µM levamisole (same recording shown in Figure 
4.1c). τo = 0.28 ms. (b) Overall, the τo of the nAChR was between 0.2 
and 0.44 ms. The τo of levamisole was significantly shorter than that of 
acetylcholine at 30 and 100 µM. It was also noted that the τo was 
decreased following the increase of levamisole concentrations. 
 
4.4.4. The mean closed-time of the nAChR presented an additional short 
component at high concentrations of levamisole. 
The mean closed-times (τc) are an important single-channel property to 
estimate kinetics of drug action. To evaluate the closed state of the ion channel, the 
duration of channel closed-time at the membrane potential of -75 mV was sorted in 
logarithmic binned histograms (Figure 4.4). The histogram was fitted with 
exponential equations to give the mean value of τc. The major component of the 
histogram was best fitted with two-exponential equation in 25 experiments and 3 
experiments were best fitted with one exponential equation. This statistical analysis 
suggests that there are two closed states of the levamisole-sensitive nAChR. The 
mean values of the two closed-times are listed in Table 4.1 for each concentration of 
agonist. Interestingly, when the ion channel was activated by 100 µM levamisole, a 
large number (20% of total) of very short closed events were present and the 
histogram was best fitted with three-exponentials (Figure 4.4c). The additional brief 
τc with a mean value of 1.06 ± 0.18 ms indicated that the ion channels rapidly 
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switched between open and closed states at high concentration of levamisole. This 
channel behavior could be explained by levamisole acting as an open channel 
blocker (Robertson and Martin, 1993) and the brief closed-time represents the 
channel block-time. 
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Figure 4.4. The change of the mean closed-times at different concentrations 
suggested the channel block effect of levamisole. When tested with 
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acetylcholine or low concentrations of levamisole (a, b), the distribution 
of closed duration was best fitted with the two-exponential equation. At 
high concentrations (100 µM) of levamisole (c), an additional component 
was visualized from the distribution histogram. This brief τc = 1.2 ms 
indicated the block-time. All histograms obtained from recordings held at 
-75 mV membrane potential. 
 
4.4.5. Single-channel kinetics of the levamisole-sensitive nAChR 
When the levamisole-sensitive nAChR was activated by acetylcholine, the ion 
channel showed a single open-state and two closed-states. We estimated the 
channel kinetics with a two closed-state model 
 
C1 C2 O 
α 
β k+1 • X 
 
k-1 
1 
 
where C1 is the 1st closed state, C2 is the 2nd closed state, O is the open state, 
X is the acetylcholine concentration, α is the channel closing-rate and β is channel 
opening-rate. In this model α was estimated by α = 1 / τo = 2900 s-1. Unlike many 
other nAChRs, this levamisole receptor lacks bursts of openings. The limited 
separation of the two major closed-times prevented accurate estimate of β, k-1 and 
k+1. 
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When the receptor was activated by a high levamisole concentration, the ion 
channel showed an additional block-state. The channel kinetics were predicted by a 
channel-block scheme (Adams, 1976; Colquhoun and Sakmann, 1985): 
 
C1 C2 O B 
α 
β k+B • X 
k-B 
k+1 • X 
k-1 
 
where B is the blocked state, X is the levamisole concentration, k+B is the 
blocking-rate constant, k-B is the unblocking-rate constant. As the previous 
discussion, the short mean closed-time represents the mean block-time. Therefore, 
k-B is estimated by the reciprocal of the short mean closed-time. At -75 mV, the value 
of k-B is calculated as 1 ms-1. The k+B was determined from the plot of the reciprocals 
of τo against drug concentrations (Figure 4.5). The relationship between 1/ τo and 
levamisole concentration at -75 mV was fitted with linear regression and the slope 
represents the k+B = 2.6 x 107 M-1s-1. Therefore, the channel-block dissociated 
constant, KB is predicted by k-B/k+B = 38 µM. The channel closing-rate α can be 
estimated by τo = 1/ (α + k+BX). The α is ~2500 s-1 and is independent of drug 
concentration. 
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Figure 4.5. Reciprocal plot of τo against levamisole concentration. When 
levamisole targeted the nAChR, it behaved as an open channel blocker. 
The mean open-time τo was shorter following the increase of 
concentrations. The relationship of 1/ τo and levamisole concentration 
was linear. The slope represents the blocking rate k+B. At a membrane 
potential of -75 mV, the blocking rate calculated from this plot was 2.6 x 
107 M-1s-1. 
 
4.4.6. The open probability of the channel (Popen) 
Unlike the neuronal nAChRs in vertebrates, we showed here that the channel 
open-time of the levamisole-sensitive nAChR in C. elegans is brief and it was rare to 
observe the overlap of multiple channel openings when more than two channels 
presented in one isolated membrane patch. Therefore, the Popen could not be 
normalized according to channel numbers present in the patch. The Popen values 
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listed here are the patch Popen rather than the channel Popen. For 10, 30 and 100 µM 
acetylcholine, the values were 0.016 ± 0.007, 0.005 ± 0.003 and 0.008 ± 0.003, 
respectively. For 10, 30 and 100 µM levamisole, the values were 0.005 ± 0.002, 
0.009 ± 0.006 and 0.015 ± 0.007, respectively. To evaluate the overall Popen, another 
factor to be considered is the percentage of active patches at each dose of agonists. 
For 10 µM acetylcholine among total 45 patches, 11 of them did not show any 
channel opening, 28 could not be analyzed due to the low frequency of channel 
opening. This means that only 13% of the patches were considered as active.  The 
active patches of 10, 30 and 100 µM acetylcholine were 13%, 64% and 71%, 
respectively. The active patches of 10, 30 and 100 µM levamisole were 32%, 28% 
and 33%, respectively. Therefore we evaluate the overall channel activity of the 
levamisole receptor at different agonist concentrations by NPopen = Popen × proportion 
of patches active. The values are listed in Table 4.1. The NPopen indicated that when 
activated by acetylcholine or levamisole, the activity of the nAChR observed on the 
lev-10 body-wall muscle was similar. 
4.4.7. The nAChR located at the membrane of body wall muscle in lev-10 
mutants were not targets of nicotine. 
Two nAChRs were found to present at neuromuscular junctions of body wall 
muscle cells in C. elegans (Richmond and Jorgensen, 1999). One is sensitive to 
levamisole and another one is sensitive to nicotine. To investigate whether the 
nAChR observed on the lev-10 body wall muscle was the levamisole-sensitive or the 
nicotine-sensitive receptor, we patched some cells with nicotine-filled pipettes. At the 
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concentration of 10 µM nicotine, no channel events were observed. For further 
confirmation, we also pulled some cell membrane patches with 10 µM levamisole to 
obtain active channels. Then a high concentration of nicotine (2 mM) was added into 
the recording chamber (5µl in approx. 1ml). Like levamisole, lipophilic nicotine is 
membrane permeable and crosses the inside-out membrane patch to target 
extracellular ligand-binding sites of the receptor (Levandoski et al., 2005). We 
assumed that if the nicotine-sensitive receptor existed in the membrane patch or 
nicotine targeted the levamisole-sensitive receptor, the addition of nicotine would 
increase the activity of the receptor or change the properties of the single-channel 
currents. However, in our experiments there was no significant change in channel 
activity or the single-channel properties from three recordings. We conclude that 
nicotine did not target the levamisole-sensitive receptor. 
4.5. Discussion 
In wild type C. elegans, nAChRs aggregate at the neuromuscular junction. 
The receptor cluster could be visualized using fluorescent labeling techniques (Gally 
et al., 2004; Gottschalk and Schafer, 2006). However, the existence of unclustered 
extra-synaptic receptors has not been demonstrated. In this single-channel study, 
18% of the membrane patches from the non-synaptic region of muscle cells showed 
acetylcholine-activated channel currents. This observation suggests that a small 
amount of extra-synaptic nAChRs exist in wild type animals. The receptor-
associated protein LEV-10 is critical for the receptor clustering (Gally et al., 2004). 
When the lev-10 gene was knocked-out, the receptor cluster was diffused from 
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postsynaptic sites but the whole-cell current remains unchanged. This suggests that 
unclustered nAChRs broadly distribute at non-synaptic regions. Based on this 
hypothesis we adapted the single-channel recording technique to investigate the 
single-channel properties of nAChRs in lev-10 mutants. 
Nicotinic receptors were observed on body wall muscle cells in lev-10 
mutants. The receptor-associated ion channel was activated by levamisole but not 
nicotine. This exclusive levamisole sensitivity indicated that the receptor observed in 
lev-10 mutants was the levamisole-sensitive receptor. Previous studies indicated 
that the levamisole-sensitive receptor contains five nAChR subunits, UNC-63, UNC-
38, UNC-29, LEV-1 and LEV-8 (Fleming et al., 1997; Richmond and Jorgensen, 
1999; Culetto et al., 2004; Towers et al., 2005; Brown et al., 2006). However, it is 
unknown that the five subunits form one or multiple subtypes (Brown et al., 2006). In 
our previous studies from other nematodes, multiple nAChR subtypes were 
activated by levamisole (Robertson et al., 1999; Qian et al., 2006) and the single-
channel properties of the multiple subtypes were physically distinguishable. The 
observations in this C. elegans study indicated that there was no evidence of more 
than one levamisole-sensitive receptor subtype. All ion channels showed a single 
conductance and single mean open-time. The results imply that we observed a 
single subtype of the levamisole receptor on body wall muscles. Previous studies 
indicate that the UNC-63, UNC-38 and UNC-29 are required for the functional 
levamisole receptor. The roles of the LEV-1 and LEV-8 subunits remain to be 
studied (Fleming et al., 1997; Culetto et al., 2004; Towers et al., 2005). 
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In wild type animals, most nAChRs aggregate at the synaptic region. In lev-10 
mutants, the levamisole receptor, but not the nicotine-sensitive receptor, was highly 
observed at the extra-synaptic region.  This observation is consistent with the 
previous suggestion that the LEV-10 protein only affects the clustering of the 
levamisole-sensitive receptor but not the nicotine-sensitive receptor (Richmond and 
Jorgensen, 1999). 
At low concentrations, levamisole, like the neurotransmitter acetylcholine, 
acts as a potent nAChR agonist. At high concentrations, levamisole also behaves as 
an open channel blocker at hyperpolarized potentials. This channel block effect of 
levamisole was also observed in other nematodes (Robertson and Martin, 1993). 
Compared with the levamisole-sensitive nAChRs in other nematodes, such as 
Ascaris and Oesophagostomum (Robertson et al., 1999; Qian et al., 2006), the 
receptor in C. elegans is exclusively sensitive to levamisole but not nicotine. It 
suggests the diversity of nAChRs in different species. 
Compared with the nicotine-sensitive receptor at neuromuscular junctions, the 
levamisole-sensitive receptor contributes a small percentage of the postsynaptic 
excitatory currents, but it plays a greater functional role in locomotion (Touroutine et 
al., 2005). It will be interesting to know the physiological functions of this receptor in 
neurotransmission. Another thing that remains to be studied is the subunit 
composition. The physiological roles of two subunits, LEV-1 and LEV-8, are unclear. 
The knock-out of either of the subunits leads to partial loss of the levamisole-
sensitive receptor but not all. It was questioned that there may be more than one 
subtype of levamisole-sensitive receptors. However, our observations are against 
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this hypothesis. We predict that a single-channel study in lev-1 and lev-8 mutants 
will help to shed a light on this controversy. 
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Chapter 5. Changes in Caenorhabditis elegans levamisole 
receptor single-channel properties in lev-1 and lev-8 
mutants 
5.1. Abstract 
Nicotinic acetylcholine receptors (nAChRs) play an important role in synaptic 
transmission. A large family of nAChR subunits has been discovered in C. elegans. 
The post-synaptic levamisole receptor, one nAChR present at the neuromuscular 
junction, is composed of essential subunits (UNC-63, UNC-38 & UNC-29) and non-
essential subunits (LEV-1 and LEV-8). Behavioral studies indicated that knockout of 
any essential subunit leads to strong levamisole resistance. Knockout of either non-
essential subunit leads to weak levamisole resistance. Previously we used lev-10 
mutants to study the single-channel properties of muscle levamisole receptors. LEV-
10 is a transmembrane protein that causes levamisole receptor clustering at the 
neuromuscular junction. In lev-10 knockouts, functional levamisole receptors are 
dispersed over the muscle cell body and are accessible for study using the patch-
clamp technique. In this study, we used lev-1;lev-10  and lev-8;lev-10 double 
mutants to investigate the single-channel properties of receptors lacking these non-
essential subunits. In both double mutants we detected levamisole activated single-
channel currents. The single-channel conductance and mean open-time of the 
double mutants were similar to that of the lev-10 single mutant, but single-channel 
events occurred at a lower frequency. We found that in the lev-1;lev-10 mutant, less 
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than 10% of the membrane patches were active and that channel opening was rare 
with NPopen = 0.0001. In the lev-8;lev-10 mutants, single-channel currents were 
present in ~40% of the experiments and NPopen was significantly less than that 
observed from the lev-10 single mutant. These observations predict a reduction in 
current flow in response to levamisole and are in close agreement with previous 
studies using the whole-cell voltage-clamp technique. 
5.2. Introduction 
Nicotinic acetylcholine receptors (nAChRs) are important for excitatory 
synaptic transmission in C. elegans. At neuromuscular junctions (NMJ) of muscle 
cells, the neurotransmitter acetylcholine released from presynaptic neurons targets 
postsynaptic nAChRs to induce muscle cell depolarization and cause muscle 
contraction. At the NMJ of body wall muscle cells, two nAChRs have been studied 
(Richmond and Jorgensen, 1999). One is sensitive to the nicotinic anthelmintic 
levamisole and named as levamisole receptors. One is sensitive to nicotine and has 
been found to contain ACR-16 as the only essential subunit (Touroutine et al., 2005). 
The levamisole receptor has been studied for its important roles in worm locomotion. 
The anti-parasitic drug levamisole targets this receptor to induce muscle contraction 
and leads to paralysis of the worm. Some genes have been found to associate with 
levamisole resistance (Fleming et al., 1997). Among these genes, unc-38, unc-63, 
unc-29, lev-1 and lev-8 were identified to encode the levamisole-sensitive nAChRs. 
The knockout mutants of unc-38, unc-63 and unc-29 are strongly resistant to 
levamisole. The subunits encoded by these genes are thought to be essential for the 
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levamisole receptor. The knockout mutants of lev-1 and lev-8 still present some 
levamisole sensitivity (Lewis et al., 1987; Fleming et al., 1997; Culetto et al., 2004; 
Towers et al., 2005). Additional to the observations of behavior phenotypes, 
levamisole-induced whole-cell currents were recorded from body wall muscle cells. 
The current recorded in the lev-1 mutant was reduced by ~85% compared with wild 
type (Culetto et al., 2004). The current recorded in the lev-8 mutant was reduced by 
~65% compared with wild type (Towers et al., 2005). The remaining part of the 
whole-cell current in lev-1 or lev-8 mutants may suggest more than one levamisole 
receptor subtype. However, our previous single-channel study disagreed with this 
suggestion. At the single channel level, only one levamisole receptor population was 
observed at muscle cells in C. elegans (chapter 4). We conclude that a single 
levamisole receptor subtype present on body wall muscle in C. elegans and this 
receptor comprises five subunits, one UNC-38, one UNC-63, one UNC-29, one LEV-
1 and one LEV-8. To investigate the roles of the non-essential subunits, LEV-1 and 
LEV-8, here we use the single-channel recording to test the lev-1 and lev-8 mutants. 
We noted that levamisole receptors were rarely observed on the muscle body 
of wild type worms. To make single-channel recording at the cell body, we used lev-
10 knockout mutants (Chapter 4). The lev-10 gene encodes a transmembrane 
protein in C. elegans (Gally et al., 2004). This protein is critical for the synaptic 
aggregation of the levamisole receptor. In knockout animals, receptor clusters are 
diffused from NMJs and the receptor was easily detected at the surface of cell body 
at the single-channel level. In this study we made lev-1;lev-10 and lev-8;lev-10 
double mutants to detect the LEV-1 or LEV-8 lacking levamisole receptor. All the lev-
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1, lev-8 and lev-10 mutants we used here contained a Mos1 sequence insert. Mos1 
is a transposon isolated from Drosophila mauritiana. This unique sequence can be 
inserted into the C. elegans genome and provides an easy way to rapidly detect the 
mutated gene (Bessereau, 2006; Boulin and Bessereau, 2007). Previous studies 
showed Mos1 as a tool to insert a mutagenesis into the lev-10 gene (Gally et al., 
2004). In this study Mos1 was inserted into lev-1, lev-8 and lev-10 genes. More 
information about Mos1-mediated mutagenesis and the lev-10 gene are available 
from Dr. Jean-Louis Bessereau’s lab (http://www.biologie.ens.fr/bcsgnce/). 
5.3. Materials and methods 
5.3.1. Worm strains  
N2, lev-10(kr26::Mos1) and unc-38(e264) were provided by the 
Caenorhabditis Genetics Center, which is funded by the NIH National Center for 
Research Resources (NCRR). Single mutants lev-1(kr105::Mos1) and lev-
8(kr136::Mos1) were provided by Dr. Bessereau’s lab at Institut National de la Santé 
et de la Recherche Médicale. All worms were grown on NGM plates seeded with 
Escherichia coli OP50. 
5.3.2. Movement assay 
Worms from the stock plates were examined using a stereo microscope. L4 
larvae were identified and incubated for 24 hours at 20°C. Then the worms were 
transferred into M9 buffer with varying concentrations of levamisole. The M9 buffer 
contains (g/L): Na2HPO4 6, KH2PO4 3, NaCl 5, MgSO4 0.12. After 1 hour, worms 
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were checked for paralysis or non-paralysis. The worms showing no movement or 
curling were considered as paralyzed. Four groups of worms (n > 10 per group) 
were tested for each levamisole concentration. 
5.3.3. Cross breeding 
L4 stage hermaphrodites were transferred to OP50 seeded NGM plates and 
heat shocked for 6 hours. Then the worms were returned to 20oC for self-fertilizing. 
The males in the F1 progeny were picked out for cross breeding. The offspring of 
cross breeding was self-fertilized and genotyped by PCR to screen for double 
mutated homozygotes. 
5.3.4. PCR 
The lev-1 gene was amplified using primers oTB263 and oTB265. The lev-8 
gene was amplified using primers oTB264 and oTB266. The lev-10 was amplified by 
primers LEV10up and LEV10dwn. The Mos1 was detected by primer oJL103. The 
primer sequences were listed in Table 5.1. The primers oTB263/265, oTB264/266 
and oJL103 were provided by Dr. Jean-Louis Bessereau. To amplify lev-1 and lev-8, 
the PCR conditions were as following: 94oC for 3 min, followed by 30 cycles of 94oC 
for 30 s, 66oC for 1 min, 72oC for 1 min. To amplify lev-10, the PCR conditions were 
as following: 94oC for 3 min, followed by 30 cycles of 94oC for 30 s, 55oC for 1 min, 
72oC for 1 min. 
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Table 5.1. Primers for PCR tests of lev-1, lev-8 and Mos1. 
Primer Name Primer Sequence
oTB263 CGTCCAGCTTCCAAAAGTCAAACTGC
oTB265 GAGGATCGCCTGATGGTCGACC
oTB264 GTCAGACCAGTTCATAATGCATCAG
oTB266 GTTGTAAAGTACAATGTCAGGGATCC
LEV10up AAAATTAATGAAAACTCAGCCATGA
LEV10dwn CAAGCTATTACCCATTGAGTACACC
oJL103 TCTGCGAGTTGTTTTTGCGTTTGAG  
 
5.3.5. Electrophysiology 
Adult worms were transferred into the recording chamber. The extracellular 
solution contained (mM): NaCl 23, NaAc 110, KCl 5, CaCl2 6, MgCl2 5, HEPES 5, D-
glucose 11 and sucrose 10. The pH of the solution was adjusted to 7.2 with NaOH. 
The osmolarity was adjusted to 330 mOsm with sucrose. The worm was immobilized 
with cyanoacrylate (GluSeal® 510K# K030574, Glustitch Inc.) onto a sylgard-coated 
coverslip. Sharp glass needles were used to cut open the cuticle. Exposed muscle 
cells were cleaned with 0.5 mg/ml collagenase solution. The dissected worms were 
used for patch-clamp experiments. The recording solution contained (mM): CsCl 35, 
CsAc 105, MgCl2 4, HEPES 10, EGTA 1 and sucrose 25, pH 7.2 adjusted with 
CsOH, 330 mOsm. The recording pipette was filled with solution containing (mM): 
CsCl 140, MgCl2 4; HEPES 10, EGTA 1 and sucrose 12, pH 7.2, 315 mOsm. 
Pipettes with resistances of 4 - 6 MΩ were used. All recordings were made using 
isolated inside-out patches. The current signal was amplified by an Axopatch 200B 
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amplifier (Axon Instruments Inc., CA, USA) filtered at 5 kHz. This single-channel 
recording method is described in our previous study (Chapter 4). 
5.3.6. Data analysis 
The raw data was digitally-filtered at 2 kHz and analyzed using pCLAMP 9 
software (Axon Instruments Inc., CA, USA). To analyze the amplitude of the single-
channel current, amplitude histograms were fitted with Gaussian equations. To 
analyze the mean open-time of the current, histograms of open duration were fitted 
with one-exponential equations. All the fits were obtained using pCLAMP 9 software. 
Statistical analysis was done with GraphPad Prism. Results are presented as mean 
± s.e.. Significance was tested by t-test and defined by p < 0.05. 
5.4. Results 
5.4.1. Levamisole resistance of lev-1 and lev-8 mutants 
To test how the LEV-1 and LEV-8 subunits affect the locomotion of worms, 
we used a paralysis assay to examine the levamisole induced paralysis of N2, lev-
1(kr105::Mos1) and lev-8(kr136::Mos1) animals. Compared to wild type animals, 
both lev-1 and lev-8 exhibited levamisole resistance (Figure 5.1). The EC50 of N2 
animals was 9 µM. The EC50 of lev-8 mutants was 40 µM. The dose dependent 
curve shifted to the right. A low percentage of lev-1 mutants showed paralysis at low 
concentrations. At high concentrations, the maximum percentage of paralyzed 
worms was 14%. As a negative control, unc-38(e264) worms showed rare paralysis 
between 1 and 100 mM of levamisole. This paralysis study is consistent with 
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previous observations that lev-1 mutants have a strong levamisole resistance and 
lev-8 mutants have a weak levamisole resistance. 
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Figure 5.1. lev-1 and lev-8 animals are partially resistance to levamisole. 
The concentration relationship of N2, lev-1 and lev-8 were fitted with 
dose-dependent curves. The EC50 of N2 animals was 9 µM. The EC50 
of lev-8 mutants was 40 µM. The maximum of lev-1 dose-dependent 
curve was 14% with logEC50 of 50 µM. The relationships of lev-1;lev-8 
and unc-38(e264) could not fitted with dose-dependent curves. 
 
5.4.2. Single-channel recording of lev-1 and lev-8 mutants 
To examine the single-channel properties of LEV-1 or LEV-8 lacking 
levamisole receptors, we made lev-1; lev-10 and lev-8;lev-10 double mutants. In 
these mutants, the mutated levamisole receptor distributed at the cell bag of body 
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wall muscles and was detectable with patch-clamp. After getting high resistance 
seals, the membrane patch was isolated and air-exposed to confirm inside-out 
configuration. 
In the lev-1(kr105::Mos1);lev-10(kr26::Mos1) double mutants, rare levamisole 
induced channel opening was observed. Considering that the low channel opening 
may be due to the receptor desensitization, we tested acetylcholine and levamisole 
as agonists at different concentrations between 10 and 100 µM. According to our 
previous experience, agonist-induced channel single-currents were observed from 
~90% of patches and ~30% were considered as active patches. In the lev-1;lev-10 
mutants, only ~20% of recordings showed convincing channel events with a low 
frequency of opening. We also used agonist-free pipette solution to patch cell 
membranes and then added levamisole into the bath solution to test whether 
desensitization caused the low frequency of channel opening. No improvement in 
channel opening was observed. From a total of 40 patches, only 2 recordings could 
be analyzed at the membrane potential of -75 mV. 
The cord conductance of the receptor is listed in Table 5.2. Not enough 
opening events were available for analysis of mean open-time. The NPopen 
(Normalized Popen) was calculated according to the average Popen of the two patches 
and the percentage of the active patches, which showed enough opening events to 
be analyzed. The NPopen at 10 µM levamisole was 0.0001 and dramatically lower 
than the NPopen observed in lev-10 single mutants (NPopen = 0.0016, Table 5.2). 
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Table 5.2. The single-channel properties of the levamisole receptor. 
Mutants ACH (10 µM) LEV (10 µM)
lev-10 30.1 ± 1.1 (n = 6) 29.3 ± 0.7 (n = 8)
g (pS) lev-1;lev-10 - 26, 28 *
lev-8;lev-10 27.4 ± 0.3 (n = 3) 30.1 ± 0.7 (n = 3)
lev-10 0.31 ± 0.03 (n = 6) 0.36 ± 0.03 (n = 8)
τ (ms) lev-1;lev-10 - -
lev-8;lev-10 0.34 ± 0.02 (n = 3) 0.30 ± 0.01 (n = 3)
lev-10 0.0021 0.0016
NPopen lev-1;lev-10 - 0.0001
lev-8;lev-10 0.0016 0.0004
* lev-1;lev-10  double mutants were tested with 10 uM acetylcholine.
However, no convincing channel opening observed from 8 patches. 
When 10 uM levamisole was used to test lev-1;lev-10  mutants,
6 of 21 patches showed channel opening and 2 were analyzed.
The conductance of the channels were listed in the table.
Due to small amount of open events, mean open time of the channels 
could not be analyzed.  
 
In the lev-8(kr136::Mos1);lev-10(kr26::Mos1) double mutants, levamisole and 
acetylcholine induced channel openings were observed frequently (Figure 5.2). 50% 
of the patches (8 of 16) showed channel openings with 10 µM acetylcholine or 
levamisole as agonists. The cord conductance was 27 and 30 pS when activated by 
acetylcholine and levamisole, respectively (Table 5.2). The conductance observed 
here was very similar to our previous results in lev-10 single mutants. It suggests 
that the channel permeability was not changed when the LEV-8 subunit was lacking. 
The channel also showed a similar mean open-time with the wild type receptor. The 
NPopen was lower in the double mutants, especially when levamisole was used as 
agonist (Table 5.2). However, channel openings were frequently observed in the 
 
 115
LEV-8 lacking mutants. It suggests that the lev-8 mutated receptor is still partially 
functional for synaptic transmission. 
 
1 pA
5 s  
Figure 5.2. The single-channel recording of lev-8 mutants. Channel opening 
events were detectable in lev-8;lev-10 double mutants with low 
frequency. No change of single-channel conductance and mean open-
time were observed. [LEV] = 10µM. Membrane potential was held at -75 
mV. 
 
5.4.3. Prediction of phosphorylation sites on LEV-1 and LEV-8 subunits 
To further investigate the differences between LEV-1, LEV-8 and other 
nAChR subunits required for the levamisole receptor, we compared the protein 
amino acid sequences (Figure 5.3). The second transmembrane domains (M2) line 
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the tunnel of the ion channel and are important for ion selectivity and permeability. 
The amino acid sequences of the M2 region are highly conserved except for the 
LEV-8 subunit. At the cytoplasmic end, the other subunits have a conserved acidic 
glutamate, but the LEV-8 subunit has a basic His288. The positive charged tunnel 
was suggested to form an anion channel instead of a cation channel (Jones and 
Sattelle, 2004). The change of this amino acid residue from Glu to His in neuronal α7 
subunit resulted in a non-functional receptor (Towers et al., 2006). However, the 
LEV-8 containing levamisole receptor is a non-selective cation channel and the 
knockout of this subunit did not improve the cation permeability. This observation 
indicates that the LEV-8 subunit is not important for ion permeability. 
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    LEV-1    (1) MMLGGGGGCGAGGTWLGFLVFLAVSLRNHSTCEDIDAEDRLMV YN DLFRG
    LEV-8    (1) ---------MWIPQRISHIFLLVIFILHIVTINANKHVSQ NLLTDLLE YN 
   UNC-29    (1) --------MRTNRLSWILVLSVVIFLVIINTINASDDEER DVFRGLMV YN 
   UNC-38    (1) -----------MRSFWLFLLLLLFCISFIKLTEGNEDAKR DLMVNLYD YN 
   UNC-63    (1) -----------MGPNDHGFAYILIFLLLSPPTHANRDANR FEDLIAD
 
                                                    - LpD      
L YN 
    - -  
    LEV-1   (51) SLVQ VRNRSELPMIVKIGMQ LIN D KE VMHTNV K QL P LVL V E Q WLTM WDDF
    LEV-8   (42) KAVR VHNASD-ALKVKFGAN LID D N VLTTSL Q KL P LCR V EV Q WLEM WYDK
   UNC-29   (43) SLIQ VRNSSELPLIVKMALQ LIN D KD VMHTNV Q QM P LVL V E Q WLTL WHDF
   UNC-38   (40) RHRR TSPNKPLTIKLKLR IID H MTCSV T KL PS- LSQ V EIDQI WLKQ WIDR
   UNC-63   (40) KLVR V-SENGETLVVTFKLK LLD H KN MTTNV S KL 
 
                                     pA       -------LpE  
P LSQ V E QI WLQH WMDY
---L --    --
    LEV-1  (101) K D YANITQIRVAPEKV L I GNYEVSFMCNVLILSTW PRD W PD VLFNNAD GT 
    LEV-8   (91) T N TDWGGVEYIHIPSDQI I Y GEPHITITSLAKIDHHW P WIPD VL NNAD GR 
   UNC-29   (93) K N VNYGEIKQIRVSPDKV L I GNYEVSFMCNVVINHKW P W PD VLFNNAD GD 
   UNC-38   (89) S D VNYGGVNVLYVPYEMI I Y SNYNITISTKATLHYTW P WVPD VL NNAD GE 
   UNC-63   (89) R D VEYGGVEVLYVPSDTI L Y GNYQVTIMTKAKLTYN
 
                 --   -- Cys Lo  --LpB--   
W P W PDVVL NNAD GT 
-       -- op---     -
    LEV-1  (151) VL A Y DVEF F LT S TYNRDEIKLDF----- WVPP I KSSCII FP DDQLCS FG W
    LEV-8  (141) VV Y NIKY K G DGETLDLYQIPVDV WQPPSI KSFCPI FPYDWQTCEM FG WSN
   UNC-29  (143) ML A Y DVEF F LV S TYNENEIKLEF----- WVPP I KSSCII FP DEQVCT FG W
   UNC-38  (139) VT A DVRW F LK S TFSENLLSVELNEPSL WEPP IFKSMCQI FP DEQQCH FG W
   UNC-63  (139) VE A Y DVEF F R K S TYGGLEVDLQHRDKHL 
 
                                        -LpF-            ----- 
WAPP I KSMCQI FP D QQCEM FG W
      
    LEV-1  (196) --------------------LTSDRVDF DGPAVLTSDR SEYSTSSIWDMM
    LEV-8  (191) DDIPQVKRQDDG----VEFLYLEKGLGL E SATSSRYAQI SFYHESA WDLL
   UNC-29  (188) --------------------VQAELVDV DVPASLVNKR SEYSASSIWDVI
   UNC-38  (189) RYEEEIDEKGIIDN----VTVAEDGIDL VE SRVAKRRAKN SDYYPS WDIM
   UNC-63  (189) EKEIEEDVEGVDGPTKEIVWVVDRGIDL VE NVPGKRHSKR 
 
                 --LpC-------          ---- ---M1----- --   
SDYYPS WDIL
    -- -- --
    LEV-1  (226) SR----------IEFQIRI TL Y IL VLMAFLNVT YLPTA RRK F TVVL PT VF
    LEV-8  (237) YPGCCGQQYYIDIKYRIII AI CMLIANVTPF LPN RRK FFTVTLTIP VFLI
   UNC-29  (218) SR----------IEFQVRI TL Y II VLMAFLSMA LPTD RRK F TVVL PT VFF
   UNC-38  (235) YPSCCPQSAYIDVTYYLQL PL Y F CVGISFLTIL YLPSD RRK F TVNLV P VF
   UNC-63  (239) YP-CC-ESPFIDITYEIHL TL Y IF VGISFLTAL YLPSD 
 
                     -------M2--------           - -----M3 
RRK F TVNL PS VF
       -- -
    LEV-1  (266) SGE LTMNV SIVV L LVSKIL P IP K L FVLNIIT KMG LL F L P TSSS LVA YLL T
    LEV-8  (287) -EH TYSISV FSV LIDLI P LS IGI F MVSVS KM LVA FYLV P TSLS L YLL TLL
   UNC-29  (258) SGE TLTISV SIVV L LVSKIL P IP K L FVLNVIT KI LL F L P TSST LMA YLL T
   UNC-38  (285) SGE TLCISI LTI LLTEII LP IGK F VMVTLS KV LVA FFL PATSIT L YLL TM
   UNC-63  (287) GGE LCISI SLTV LLVEII S VIP IGK F VLVTLS 
 
                 --------                                      
KIS LI FFL P TSL L YLL TM
--     
    LEV-1  (316) IMVTTIIC YFRSPITHRLPP VRKV LDI LMCMQRPHRKNVIQRS NI W F LPL
    LEV-8  (336) IILSVVTI YRKQAFSSGMSH RWL R KLLRLKTLEHTLGPDEG NM WQ FVQ LP
   UNC-29  (308) ILVTVIII YFRGPRTHRMPQ VRVV LQF KLVCMKRPKSASERS-A NV W F LP
   UNC-38  (335) VVVTVISL FRTPTTHLMPN VKKV LKW KLLFMRRP------IDD NLH W F LP
   UNC-63  (337) VVVTVVTL YRSPTTHTMPK RL F KYLLMTRPQ-----PPG 
 
                                                                    
NVH WMK FVD LP
    LEV-1  (366) HRRLLETG------PSVEENPMRSGEHHPLCRHT-HN-QDSCRRVRIQSD 
    LEV-8  (386) SETTTPRTGSVSVTASVTQRTLNPNNNSPVFPPQRLRLLSLVQMDEALKQ 
   UNC-29  (357) VRSGMAQL------PGVGQFTLSPSAHHPLCPSA-DDRTTTIRNTASNET 
   UNC-38  (379) YEEKFDDK------KKPKDGKIALSVHAHRVSN----VGNNIRNATIDDT 
   UNC-63  (382) HHSKPNRK------FDSRASTFSIGVNHVLGQNS-ELLSPGLNSNREESS 
 
                                                                --- 
    LEV-1  (408) ELDDELSPEAQRAIDAIEF ENRRDEEITKQFRDD KFIASVV FLIT W DR LY 
    LEV-8  (436) RCAADNLDLFRKIAGHLKI HFHNQQMEGKITEE QLMSLVI FISA W DRI LI 
   UNC-29  (400) SAYYPLSTDALRAIDAIEY EHLKRDEQHKSFRDD KYVAMII LIT W DRL LY 
   UNC-38  (419) IQKMYYSPPVVKAFENICF AELLKKKDRDDKIDED KYVAMVL FI W DRL LL 
   UNC-63  (425) FTLPRDNSPVRSAVESVAY ADHLKNEEDDKQVIED KYISVVM F
 
                 -----M4--------                                    
I W DRI LI 
    LEV-1  (458) G ATVGGTIGIIFTA FETFDENATLVKLKQLYDMGLANDTVLGIF FFG PSV
    LEV-8  (486) L VSMAANIMFVYNS FDDRPSLVPSVAHKPLSGGTINVLNT---- FLA PTL
   UNC-29  (450) V ITVGGTCGILFSA FQRIDQQEMLDRLKEKYDTASNIP------ FFG PHV
   UNC-38  (469) I ACFVGTVIILLRA YDTRQPIDLQYRPANLSANPISF------- FSI PTL
    UNC-63  (475) T ACAFGTVVIIARA YDNTPALA---------------------- FTF PSI
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Figure 5.3. Amino acid sequences of the five levamisole receptor subunits. 
The protein alignment was constructed using Vector NTI. The six loops 
of ligand binding domains and four transmembrane domains are 
indicated. The histidine at the cytoplasmic ends of the subunits is 
conserved except LEV-8. Between M3 and M4 each subunit has a large 
intracellular loop, which has multiple putative phosphorylation sites. The 
region is predicted to be important for receptor regulation. 
 
All the subunits have a large intracellular domain between M3 and M4. The 
amino acid sequences of this region are less conserved and important for the 
modulation of receptors. Phosphorylation sites of the subunits were predicted using 
NetPhos (http://www.cbs.dtu.dk/services/NetPhos/) and NetPhosK 
(http://www.cbs.dtu.dk/services/NetPhosK/). The putative phosphorylation sites are 
listed in Table 5.3. At the intracellular loop of LEV-1 and LEV-8 subunits, multiple 
tyrosine and serine sites were expected to be phosphorylated by CaM kinases or 
other protein kinases, especially protein kinase C. In nematodes, CaM kinase has 
been shown to potentiate levamisole responses of somatic muscle cells (Trailovic et 
al., 2002). PKC is also highly involved in the modulation of nAChRs. It has been 
demonstrated that in C. elegans PKC encoded by the tpa-1 gene is essential for the 
down-regulation of levamisole receptors (Waggoner et al., 2000). The intracellular 
loop of the UNC-29 subunit, which is essential for functional levamisole receptors, 
also has three putative phosphorylation sites for PKC and one site for PKA or PKG. 
The UNC-63 and UNC-38 subunits showed relatively fewer phosphorylation sites. 
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The analysis implies that LEV-1, LEV-8 and UNC-29 may play important roles in 
channel modulation. 
 
Table 5.3. The phosphorylation sites of the five subunits. 
Kinase Kinase Kinase Kinase Kinase
S 395 PKC S 397 PKC T 324 PKC S 332 PKC S 352 PKC
S 418 CaMK S 350 PKA S 366 PKC S 386 CaMK
S 423 PKA PKG T 372 PKC T 389 CaMK
S 436 PKG S 352 PKC S 398 PKC S 400 PKA
T 389 PKC S 406 CaMK S 397 PKC
PKA S 425 PKA
PKB PKB
S 414 CaMK
LEV-8
Site Site Site Site Site
UNC-63 UNC-38 UNC-29 LEV-1
 
 
5.5. Discussion 
The levamisole receptor located at the NMJ of body wall muscles has a 
critical role in locomotion of nematodes. The levamisole sensitive nAChR exhibits 
worm specific characteristics compared with vertebrate nAChRs and is important for 
studies of anti-parasitic drugs and drug resistance. One question of interest to 
scientists is: is there only one subtype of levamisole receptor or more than one 
subtype? Previous results from levamisole resistance assays and whole-cell patch 
clamp suggest the existence of more than one subtype, because the knockout of 
lev-1 or lev-8 only causes partial loss of levamisole responses. Given the facts that 
LEV-1 containing receptors contribute ~85% and LEV-8 containing receptors 
contribute ~65% of the whole-cell levamisole current (Culetto et al., 2004; Towers et 
al., 2005), we believe that the majority of levamisole receptors is one subtype of 
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nAChRs, which contains both LEV-1 and LEV-8 subunits. Our previous single-
channel study of the levamisole receptor in the lev-10 single mutant supported this 
hypothesis. We only observed one ion channel population. The LEV-1 and LEV-8 
subunits are not necessary for forming pentameric ligand-gated ion channels, but 
they may play important roles to modulate the ion channel activity. As we showed in 
this study, although the levamisole receptor was observed in lev-1 and lev-8 mutants, 
the channel opening was much less than the normal levamisole receptor. We also 
determined that the percentage of active membrane patches was significantly lower 
in lev-1 lacking receptors than normal receptors. This may suggest the number of 
the levamisole receptors on the cell surface was decreased. 
The intracellular loop between M3 and M4 is important for receptor subunit 
modulations. Multiple putative phosphorylation sties exist on the intracellular loop of 
LEV-1 and LEV-8 subunits. These sites are predicted to be targets of protein 
kinases and CaM kinases. In nematodes the nAChR activity could be modulated by 
kinases directly (Trailovic et al., 2002). Furthermore, these tyrosine, serine and 
threonine sites may also be phosphorylated by other kinases, i.e. tyrosine kinases 
and G-protein-linked receptor kinases (GRKs), to modulate the receptor endocytosis, 
desensitization and protein association (Gainetdinov et al., 2004). Nicotinic AChRs 
in C. elegans are known to associate with many transmembrane or intracellular 
proteins (Gottschalk et al., 2005). Some of the nAChR-associated proteins serve as 
modulators to regulate the channel activity. Some of the proteins, such as LEV-10 
(Gally et al., 2004), are related to receptor expression and localization. To conclude, 
nAChRs lacking either LEV-1 or LEV-8 are open less frequently than normal 
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levamisole sensitive nAChRs. We hypothesize that normal levamisole sensitive 
receptors are positively modulated by phosphorylation. The lack of channel activity 
in lev-1 and lev-8 mutants corresponds to a lack of phosphorylation sites present in 
channels containing those subunits. 
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Chapter 6. General discussion 
Three pharmacological nAChR subtypes have been described in our previous 
studies (Robertson et al., 2002). Here we observed the three subtypes at the single-
channel level. We tested the single-channel properties and pharmacological 
properties. Each subtype exhibited individual channel conductance, mean open-time 
and Popen. Levamisole sensitivities of the subtypes are also different. It has been 
found that levamisole resistant nematodes lost some levamisole-sensitive nAChR 
subtypes (Robertson et al., 1999). The L-type nAChR in Ascaris is the most 
sensitive subtype and may play an important role in producing levamisole resistance, 
because the opening of L-type receptors contributes most of the levamisole induced 
inward current. If this subtype is missing, the worm will exhibit levamisole resistance. 
Paraherquamide and 2-desoxyoparaherquamide, two novel nicotinic anthelmintic 
compounds, act as competitive antagonists of nematode nAChRs and the inhibitory 
effects are subtype selective. Paraherquamide treatment inhibits normal cholinergic 
transmission at neuromuscular junctions and induces flaccid paralysis of parasitic 
nematodes. Paraherquamide and 2-desoxyoparaherquamdie are potential 
anthelmintic drugs. 
The free living nematode C. elegans is commonly used as a model animal for 
drug resistance studies. More than 20 nAChR subunits have been found in C. 
elegans. When some of the subunits were knocked out, the nematode produced 
levamisole resistance. It is believed that a levamisole sensitive nAChR composed of 
these subunits is involved in levamisole resistance. We observed this levamisole 
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receptor at the single-channel level. The single-channel properties of the levamisole 
receptor in C. elegans showed some similarity with L-type nAChRs in Ascaris suum, 
but were not identical. In Ascaris, two other nAChR subtypes, N- and B-type, are 
also activated by levamisole. In C. elegans, we observed one levamisole sensitive 
nAChR type. An additional levamisole-insensitive nAChR exists at the 
neuromuscular junction of C. elegans (Richmond and Jorgensen, 1999). In our 
experiments we could not detect this subtype and test its single-channel properties. 
We estimate that both Ascaris suum and C. elegans have multiple nAChR subtypes 
at the neuromuscular junctions. The levamisole sensitivity of these subtypes is 
different. Loss of levamisole sensitive subtypes is one mechanism for levamisole 
resistance. 
Two levamisole receptor subunits, LEV-1 and LEV-8, are not essential to form 
levamisole receptor pentamers. They may play important roles in receptor 
modulation. When LEV-1 or LEV-8 was absent, the ion channel was less active. 
nAChR subunits have a large intracellular loop between transmembrane domain 3 
and 4. We analyzed putative phosphorylation sites on the intracellular loop. The 
LEV-1 and LEV-8 subunits have multiple phosphorylation sites for CaM Kinases and 
protein kinases, especially PKC. Our previous studies in parasitic nematodes 
indicated that CaM Kinases and protein kinases directly regulate nAChR channel 
activity (Trailovic et al., 2002). It is reasonable to hypothesize that the LEV-1 and 
LEV-8 play important roles in receptor modulation, and receptor activity was 
inhibited in lev-1 or lev-8 knockout mutants. Another possible modulation is protein 
association. It was known that nAChRs are associated with many transmembrane 
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and intracellular proteins, which regulate nAChR functions. We believe that further 
understanding of receptor modulation will give us the possibility to enhance 
nematode responses to anthelmintic drugs and reverse drug resistance. 
Phosphorylation of nAChRs has been showed to modulate receptor activity in 
the nematode Ascaris suum. We expect that protein kinases also modulate 
levamisole receptors in C. elegans. For further investigation of this hypothesis, we 
can either apply protein kinase catalytic subunits and ATP to test channel activity, or 
use some genetic manipulated mutants such as TAX-6 to investigate effects of 
phosphorylation. Another future study interesting to us is that the role of nicotine 
sensitive nAChRs. This nAChR subtype has been showed to contribute ~80% of the 
whole-cell current induced by acetylcholine, but the knockout of this nAChR has no 
observable phenotype. The nicotine sensitive receptor and levamisole sensitive 
receptor may have different Ca2+ permeability or induce different Ca2+ cascade. To 
investigate the Ca2+ permeability of nicotine sensitive nAChRs, I propose to use Ca2+ 
imaging or patch-clamp technique to test the Ca2+ permeability in levamisole 
receptor knockout mutants. To investigate the Ca2+ permeability of levamisole 
sensitive nAChRs, I propose to use same techniques in acr-16 knockout mutants. 
The results will indicate the contribution of the two nAChR subtypes to whole-cell 
Ca2+ entry and the roles of the two nAChRs in muscle contraction. 
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